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A B S T R A C T
Background
Many people with chronic disease have more than one chronic condition, which is referred to as multimorbidity. While this is not a new
phenomenon, there is greater recognition of its impact and the importance of improving outcomes for individuals affected. Research
in the area to date has focused mainly on descriptive epidemiology and impact assessment. There has been limited exploration of the
effectiveness of interventions for multimorbidity.
Objectives
To determine the effectiveness of interventions designed to improve outcomes in patients with multimorbidity in primary care and
community settings. Multimorbidity was defined as two or more chronic conditions in the same individual.
Search methods
We searchedMEDLINE, EMBASE, CINAHL, CABHealth, AMED, HealthStar, The Cochrane Central Register of Controlled Trials
(CENTRAL), the EPOC Register and the Database of Abstracts of Reviews of Effectiveness (DARE), and the EPOC Register in April
2011.
Selection criteria
We considered randomised controlled trials (RCTs), controlled clinical trials (CCTs), controlled before and after studies (CBAs), and
interrupted time series analyses (ITS) reporting on interventions to improve outcomes for people with multimorbidity in primary care
and community settings. The outcomes included any validated measure of physical or mental health, psychosocial status including
quality of life outcomes, well-being, and measures of disability or functional status. We also included measures of patient and provider
behaviour including measures of medication adherence, utilisation of health services, and acceptability of services and costs.
Data collection and analysis
Two review authors independently assessed studies for eligibility, extracted data, and assessed study quality. Meta-analysis of results was
not possible so we carried out a narrative synthesis of the results from the included studies.
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Main results
Ten studies examining a range of complex interventions for patients with multimorbidity were identified. All were RCTs and there
was low risk of bias. Two of the nine studies focused on specific co-morbidities. The remaining studies focused on multimorbidity,
generally in older patients. All studies involved complex interventions with multiple elements. In six of the ten studies, the predominant
intervention element was a change to the organisation of care delivery, usually through case management or enhanced multidisciplinary
team work. In the remaining four studies, the interventions were predominantly patient oriented. Overall the results were mixed with
a trend towards improved prescribing and medication adherence. The results indicate that it is difficult to improve outcomes in this
population but that interventions focusing on particular risk factors or functional difficulties in patients with co-morbid conditions
or multimorbidity may be more effective. Cost data were limited with no economic analyses included, though the improvements in
prescribing and risk factor management in some studies provided potentially significant cost savings.
Authors’ conclusions
This review highlights the paucity of research into interventions to improve outcomes for multimorbidity with the focus to date being
on co-morbid conditions or multimorbidity in older patients. The limited results suggest that interventions to date have had mixed
effects but have shown a tendency to improve prescribing and medication adherence, particularly if interventions can be targeted at risk
factors or specific functional difficulties in people with co-morbid conditions or multimorbidity. There is a need for clear definitions
of participants, consideration of appropriate outcomes, and further pragmatic studies based in primary care settings.
P L A I N L A N G U A G E S U M M A R Y
Improving outcomes for people with multiple chronic conditions
Many people with chronic disease have more than one chronic condition, which is referred to as multimorbidity. This review aimed
to identify and summarise the existing information about the effectiveness of any healthcare programmes or interventions to improve
outcomes for people with multimorbidity in community settings. We identified ten studies, some of which focused on specific
combinations of conditions, whereas others focused on multiple conditions in general, particularly in elderly patients. The majority
of interventions involved changes to the organisation of care delivery though some studies had more patient focused interventions.
There were mixed effects on physical health status but some improvements in prescribing and taking medication. Overall the results
indicate that it is difficult to improve outcomes in this population, but that focusing on particular risk factors or functional difficulties
in patients with co-morbid conditions or multimorbidity may be more effective. There is a need for further studies on this topic.
B A C K G R O U N D
There has been increasing focus on the enormous personal and
societal burden of ill-health caused by chronic disease. The World
HealthOrganization has emphasized the importance of organising
healthcare delivery systems to improve health outcomes and have
stressed the importance of building integrated healthcare systems
that can address chronic disease management (WHO 2002). This
can be done by focusing on generic chronic care models, as has
happened mainly in the USA, or by developing national systems
focusing on single chronic conditions as has happened with the
National Service Frameworks in the UK (Lewis 2004). However,
many people with chronic disease have more than one chronic
condition, which is referred to as multimorbidity (Fortin 2005).
While this is not a new phenomenon, there is greater recognition
of its impact and the importance of improving outcomes for in-
dividuals affected (Fortin 2007; Smith 2007).
How interventions might work
Given the complexity of managing patients with multiple chronic
conditions, potential interventions are likely to be complex and
multifaceted if they are to address the varied needs of these patients.
We anticipated that a variety of intervention types could work to
improve outcomes for patients with multimorbidity and could be
included within the scope of this review. The EPOC Cochrane
review group have developed a taxonomy that defines intervention
types. We have used this taxonomy to define health service and
patient oriented interventions that have been designed to improve
outcomes of people or populations with more than one chronic
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condition.
1. Professional interventions: For example, education designed to
change the behaviour of clinicians.
Such interventions may work by altering professionals awareness
of multimorbidity or providing training or education designed
to equip clinicians with skills in managing these patients thus
improving their healthcare delivery.
2. Financial interventions: For example, financial incentives to
providers to reach treatment targets.
Such interventions might work by incentivising health service de-
livery and providing resources to extend consultation length for
patients with multimorbidity.
3. Organisational interventions: These can be further divided into
organisational changes delivered through practitioners or directly
to patients. For example, any changes to care delivery such as case
management or the addition of different healthcare workers such
as a pharmacist to the healthcare team.
Such interventions may work by changing care delivery to match
the needs of patients with multimorbidity across a range of areas
such as coordination of care, medicines management, or use of
other health professionals such as physiotherapists and occupa-
tional therapists to address needs relating to physical and social
functioning.
4. Patient oriented interventions: This would include any inter-
vention directed primarily at patients, for example, patient edu-
cation or support for self-management.
Such interventions might work by improving self-management,
thus enabling patients to manage their conditions more effectively
and to seek appropriate health care.
5. Regulatory interventions: For example, changes to local or na-
tional regulations designed to alter care delivery in order to im-
prove outcomes.
Such interventions might work by introducing regulatory changes
that facilitate and enable the funding of care that is directed to-
wards those with complex health needs. An example could be the
introduction of free primary care for patients with multimorbidity
on the basis that preventive care might prevent subsequent more
costly hospital admissions. While we did not find these types of
interventions, we believe they could exist and would fall within
the scope of this review for future updates.
We anticipated that organisational type interventions might pre-
dominate.We were aware that there had been a focus on case man-
agement, based mainly in healthmaintenance organisations in the
USA. There is a Cochrane review of case management being car-
ried out (Zwarenstein 2000) which is investigating whether case
management may improve health outcomes. In that review, case
management is defined as the explicit allocation of co-ordination
of tasks to an appointed individual or group and it is postulated
that the function of co-ordination is so important and specialised
that responsibility for carrying it out needs to be explicitly allo-
cated. Our review included studies where case management was
employed but only if it was specifically directed towards individ-
uals identified as having multimorbidity.
The implementation of the Family Medicine Groups in the
Province of Quebec, Canada, was another example of an organisa-
tional intervention as it involved new forms of shared responsibil-
ities between physicians and nurses (Clair 2000). Another exam-
ple in the UK was the community matrons programme, which is
being delivered through primary care trusts and is based on nurse
provided case management for patients with complex care needs
including those with multimorbidity (London DOH 2005). It is
similar to previous programmes delivered through social services
in the 1990s and there have been concerns expressed at the feasi-
bility of achieving the programme targets without real integration
of primary and specialist services (Murphy 2004).
There have been no reviews of the effectiveness of such interven-
tions for patients with multimorbidity.
Why it is important to do this review
Individualswithmultimorbidity aremore likely to die prematurely
(Poses 1996), be admitted to hospital, (Librero 1999) and have
longer hospital stays (Rochon 1996). They have poorer quality
of life, loss of physical functioning (Bayliss 2004; Fortin 2004;
Fortin 2006a), are more likely to suffer from depression, and to
be receiving multiple medications consequently having difficulties
with adherence (Townsend 2006). Prevalence studies ofmultimor-
bidity have been carried out in different countries indicating that,
particularly in those over 60, the majority of patients attending
family primary care services had more than one chronic condition
(Fortin 2006b;Hoffman 1996; van den Akker 1998;Wolff 2002).
A subgroup of these patients have a debilitating combination of
conditions that have a high impact on their own lives but also on
their utilisation of health services (Parmelee 1995; Smith 2008).
These individuals, who could be referred to as having high impact
multimorbidity, can be difficult to manage, resulting in frequent
health care visits, frequent emergency hospital admissions, and re-
peated investigations with enormous cost for the individuals and
for the healthcare system involved. A UK report has examined the
costs associated with this group of patients who are described as
’high impact users’ on the basis of their frequent emergency ad-
missions (Foster 2006).
There is a clear recognition of the need for integrated care of mul-
tiple conditions (Stange 2005). The clinical care of these patients
is complex. The evidence base for managing chronic conditions
is based largely on trials of interventions for single conditions
and individuals with multimorbidity are often excluded from such
studies. (Fortin 2006b; Starfield 2001). Their clinical care may be
fragmented with involvement of both primary care and multiple
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specialists who may not be communicating effectively with each
other. Starfield has found that patients with a high morbidity bur-
den have a higher use of specialists even for conditions that are
normally managed in primary care, and concludes that there is
a need for a better understanding of the roles of generalists and
specialists in managing these patients (Starfield 2005).
O B J E C T I V E S
To determine the effectiveness of health service or patient oriented
interventions designed to improve outcomes in patients with mul-
timorbidity in primary care and community settings. Multimor-
bidity was defined as two or more chronic conditions in the same
individual.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomised controlled trials (RCTs), controlled
clinical trials (CCTs), controlled before and after studies (CBAs)
meeting EPOC quality criteria, and interrupted time series anal-
yses (ITS) (where there is a clearly defined point in time when
the intervention occurred and at least three data points before and
three data points after the intervention). Studies published in all
languages were eligible for inclusion.
Types of participants
Participants included people or populations with multimorbidity
receiving care in a primary or community care setting.We adopted
the most widely used definition of multimorbidity, that is, the co-
existence of multiple chronic diseases and medical conditions in
the same individual, usually defined as two or more conditions
(Fortin 2004; van den Akker 1998).We used theWHOdefinition
of chronic disease, which is “health problems that require ongoing
management over a period of years or decades” (WHO 2002).
We included all studies that identified participants or sub-groups
of participants on the basis of multimorbidity, as defined by the
study authors. We did not include studies or groups of patients
within studies where multimorbidity was assumed to be the norm
on the basis of patients’ age as the interventions were not being
targeted specifically at multimorbidity and its recognised compli-
cations. This included studies where interventions were directed
at communities of people based on location or age of participants
in which participants were presumed to have multimorbidity on
the basis of their age or residence in a nursing home.
Types of interventions
We included any type of intervention that was specifically directed
towards a group of patients defined as having multimorbidity.
Only interventions based in primary care and community settings
were included. Interventions included family doctors, nurses, or
other primary care professionals. Primary health care was defined
as providing “integrated, easy to access, health care services by
clinicians who are accountable for addressing a large majority of
personal health care needs, developing a sustained and continuous
relationship with patients, and practicing in the context of fam-
ily and community” (Vaneslow 1995). However, not all countries
have clearly defined primary care systems (Starfield 1998) so we
included care delivered in community settings by individuals ful-
filling the basic criteria for primary care, i.e. if they are available to
treat all common conditions in all age groups and have an ongoing
relationshipwith their patients.While some specialistsmay deliver
components of primary care to their patients, practitioners were
not included unless they fulfilled the definition of being available
to treat all conditions and have an ongoing relationship with their
patients.
Interventionswere classified as ’simple’ if they used one identifiable
component or multifaceted if they incorporated more than one
feature.
We categorised interventions using the EPOC taxonomy pre-
sented in the Background section. Where interventions had mul-
tiple elements, we defined each element within the taxonomy
and highlighted the predominant element of the intervention. See
Table 1.
The following interventions were excluded:
• Professional educational interventions or research initiatives
where there was no specified structured clinical care delivered to
an identified group of patients with multimorbidity.
• Interventions targeted at one condition only. This
commonly occurs where people with an identified chronic
condition are screened for co-morbid depression and are then
treated for depression.
• Interventions targeted at co-morbid conditions where the
intervention was targeted solely at one condition. This
commonly arises in relation to chronic disease and co-morbid
depression, so called ’depression plus one studies’. These are
increasingly common as the link between depression and most
chronic conditions has now been well established. We therefore
excluded such studies if the intervention was only targeted at the
depression and did not take into account the full extent of the
multimorbidity.
Types of outcome measures
Studies were included if they reported any objective, validated
measure of:
• Patient physical or mental health outcomes.
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• Patient psychosocial outcomes including quality of life
outcomes, well-being, and measures of disability or functional
status.
• Utilisation of health services including hospital admissions.
• Patient behaviour including measures of medication
adherence, and other objective measures such as goal attainment
(Cox 2002; Gordon 1999; Kiresuk 1968). Self-report behaviour
outcomes were included if they were measured with a validated
scale.
• Provider behaviour.
• Acceptability of the service to patients and providers, if this
was reported in a study that reported patient outcomes or
provider behaviour.
• Economic outcomes including full economic analyses
incorporating measures of efficiency or effectiveness in relation
to costs or direct costs depending on what was reported in
included studies.
Attitude and knowledge outcomes were excluded during the
preparation of the protocol as we wanted to include objective mea-
sures of professional behaviour or patient outcomes. Treatment
satisfaction was included if it was reported in a study that also
reported other objective outcome measures.
Search methods for identification of studies
Electronic searches
The search strategy was particularly challenging given the lack
of a mesh term for multimorbidity. In addition, we were aware
from existing epidemiological literature that the recognition of
multimorbidity as a concept is relatively recent. Multimorbidity is
sometimes used synonymously with the term comorbidity, though
this tends to be used in relation to diseases that coexist with an
index disease under study (de Groot 2004). However, comorbidity
is a MeSH term, whereas multimorbidity is not, so we included
both terms in our search. For pragmatic reasons we limited the
MEDLINE search to articles indexed from 1990 onwards.The
following electronic databases were searched in April 2011:
Database Name Interface
AMED --Allied & Complimentary Medicine (1985- current) Ovid
CAB Abstracts (1973-current) Ebsco
CINAHL-Cumulataive Index to Nursing & Allied Health Liter-
ature (1981-current)
Ebsco
Cochrane Library (CENTRAL) Wiley
EMBASE (1980-current) Ovid SP
EPOC Register (from The Effective Practice & Organization of
Care Group, Cochrane Collaboration)
Reference Manager
HealthStar (1999 - current) Ovid SP
MEDLINE (1990-current) Ovid SP
MEDLINE In-Process & Other Non-Indexed Citations Ovid SP
MEDLINE Daily Update Ovid SP
DARE Wiley
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The search strategy published in the protocol was not used and
the search strategy recorded for the 2007 search of MEDLINE
was revised in 2009 to better capture the concept of multimorbid-
ity. Results of the search were limited by filters for study design
and an extensive list of intervention terms. Search strategies are
provided in appendices as follows: MEDLINE Appendix 1; EM-
BASE Appendix 2; CAB Abstracts Appendix 3; Cochrane Central
Register or Controlled Trials Appendix 4; CINAHL Appendix 5.
The MEDLINE strategy was used in Healthstar and AMED; the
Cochrane search strategy was used in DARE.
Searching other resources
(a) Reference lists of all included papers were searched.
(b)Authors of relevant paperswere contacted regarding any further
published or unpublished work.
(c) We had planned to contact authors of other reviews in the field
of multimorbidity that were retrieved during the search process
regarding relevant studies that they may be aware of, but no other
reviews were identified.
Data collection and analysis
Obtaining studies and determining eligibility for the
review
Potentially relevant studies were determined by review of the ab-
stracts of search results. Full text copies of all articles identified as
potentially relevant were retrieved. Two review authors (SS and
HS) independently assessed each retrieved article for inclusion.
Data abstraction
Two review authors (SS and HS) undertook data abstraction and
cross checked data abstraction forms using a modified version of
the EPOC data collection checklist. Disagreements about eligi-
bility and quality were resolved by consensus between the review
authors. Where questions remained, we planned that the abstract
would be reviewedby a third review author or, if necessary, by refer-
ral to the Cochrane contact editor. We referred one study (Zhang
2008) to EPOC regarding its design and this was excluded.
Quality
The risk of bias in all included studies was assessed by two inde-
pendent review authors using standard EPOC criteria (see ADDI-
TIONAL INFORMATION, ASSESSMENT OF METHOD-
OLOGICAL QUALITY under GROUP DETAILS).
The following data were extracted for all included studies:
(1)Details of the intervention: a full descriptionof the intervention
was extracted as were details regarding aims; clinical protocols;
use of case workers; remuneration/ payment systems; providers
involved; and theoretical framework on which the intervention
was based.
(2) Participants:
• Patients: nature of multimorbidity and how determined
• Providers: specialist and primary care providers involved;
family members
(3) Clinical setting.
(4) Study design.
(5) Results. Results were organised into:
• Health outcomes
• Psychosocial outcomes including quality of life outcomes
• Process of care including health service utilisation and
changes in patient and provider behaviours
• Patient and provider acceptability
• Economic outcomes. We reported the economic outcomes
of eligible studies. Where economic analyses were available
linking costs to effectiveness or efficiency, we planned to provide
details on the measures used by authors. Where direct costs were
reported alone, we indicated whether these costs related to
society, the health service, or the patients. We also reported,
where possible, costs in relation to the specific year and currency
presented; whether costs related to total costs or simple fees
charged; what was included in the cost calculations; and over
what time period costs were calculated.
Reporting
We reported data in natural units for each study.
For RCTs, we reported results in terms of:
(1) Absolute difference (mean or proportion of outcome in inter-
vention group minus control at study completion).
(2) Relative percentage difference (absolute difference divided by
post-intervention score in the control group).
Standardised effect sizes are presented in tables where possible, i.e.
where studies reported relevant data for their calculation.
For ITS we had planned to report two effect sizes:
(1) The change in the outcome immediately after the introduction
of the intervention.
(2) The change in the slope of the regression lines.
However, no ITS studies were identified.
If data were missing, authors were contacted to obtain the infor-
mation.
Data analysis
Analysis of primary outcomes
Included studies measured similar outcomes using different meth-
ods. These included either continuous variables (such as blood
pressure) or dichotomous process measures (such as proportion
of patients with diabetes receiving a structured annual review for
complications).
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Standardised effect sizes for continuous measures were calculated
by dividing the difference inmean scores between the intervention
and comparison group in each study by an estimate of the pooled
standard deviation.
We planned to carry out meta-analysis if studies were identified
that were similar in terms of settings, patients, interventions, out-
come assessment and study methods. However, this was not pos-
sible so we carried out a narrative synthesis of the results from the
included studies.
Methods for reanalysis of RCTs, CCTs and CBAs with
potential unit of analysis errors
Weplanned to re-analyse studies with unit of analysis errors, where
indicated and where possible. None of the included studies had
unit of analysis errors.
Methods for reanalysis of ITS comparisons with
inappropriate analysis
We planned to use time series regression to re-analyse each com-
parison, where indicated and where possible. Additional analyses
of ITS would have been based on EPOC criteria. No ITS studies
were identified
Additional analyses
Subgroup analyses
We had planned, if possible, to consider subgroup analyses based
on the degree of multimorbidity of participants. This would have
been based on the number of conditions per person. This was not
possible.
Exploring heterogeneity
We planned to prepare tables and funnel plots comparing effect
sizes of studies grouped according to potential effect modifiers
(for example, simple versusmultifaceted interventions) if sufficient
studies had been identified.
If there had been enough studies, we had planned to use meta-
regression to see whether the effect sizes could be predicted by
study characteristics. These could, for example, include duration
of the intervention, age groups, and simple versus multifaceted
interventions (Cooper 1994). We also considered formal tests of
homogeneity (Petitti 1994). None of these quantitative methods
were possible for this version of the review but will be considered
for future review updates.
Ongoing studies
Ongoing studies were identified and described where possible to-
gether with an estimate on reporting date if available.
R E S U L T S
Description of studies
Search results
The search was carried out in January 2007, and repeated inOcto-
ber 2008, February 2009 and April 2011. The following number
of articles were identified in each database (following removal of
duplicates):
MEDLINE: 15984
EMBASE: 2647
CINAHL, CAB Health and EPOC: 1546
Total: 20177
The search process is outlined in Figure 1. Thirty full papers were
screened for eligibility by two reviewers (SS andHS) andwe sought
advice on the eligibility of one paper from the EPOC editorial
base. Details of the 17 excluded papers are provided in the Table:
Characteristics of excluded studies.
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Figure 1. Study flow diagram.
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We identified three ongoing studies which are described in the
Table: Characteristics of ongoing studies.
Overview of included studies
We identified ten studies eligible for inclusion in the review (seeTa-
ble: Characteristics of included studies). All ten were randomised
controlled trials (RCTs). There were a total of 3357 patients in-
cluded. The studies varied in duration from eight weeks to two
years, with the majority lasting 6-12 months.
Eight of the ten studies included patients with a broad range of
conditions (Boult 2011, Eakin 2007, Gitlin 2006, Hocchalter
2010, Hogg 2009, Krska 2001, Lorig 1999 and Sommers 2000),
whereas the remaining two focused more on comorbidities: co-
existing depression and hypertension (Bogner 2008); coexisting
depression and diabetes and/ or heart disease (Katon 2010). All
were set in primary care or community settings in the USA, apart
fromKrska 2001 which was set in the UKNational Health Service
and Hogg 2009 which was set in Canada. Five were funded by a
government or university grant (Gitlin 2006, Hogg 2009, Katon
2010, Krska 2001, Lorig 1999) and the remaining studies were
funded by charitable foundations. None were funded directly by
the pharmaceutical industry.
In themajority of included studies, the comparator was usualmed-
ical carewhichwas supplemented by anewsletter or leaflet inEakin
2007 andGitlin 2006 or assessment but no follow-on intervention
in Bogner 2008, Katon 2010 and Krska 2001. Hocchalter 2010
was the only study that used an attention control, with control
patients also attending a group session, but one which was based
on an unrelated topic. No study specifically reported consumer
involvement in the intervention design.
Description of interventions
The interventions were all multifaceted and brief descriptions for
each study are provided in the Characteristics of included studies
table.
As outlined in themethods, we used the EPOC taxonomy of inter-
ventions to describe and categorise the interventions tested in these
studies. While the interventions identified all involved multiple
components they could be divided into twomain groups: Predom-
inantly organisational interventions (Bogner 2008, Boult 2011,
Hogg 2009, Katon 2010, Krska 2001, Sommers 2000) or predom-
inantly patient oriented (Eakin 2007, Gitlin 2006, Hocchalter
2010, Lorig 1999).No study involving financial or regulatory type
interventions were identified. We have included an additional ta-
ble which outlines intervention elements and indicates which el-
ements featured in each of the included studies (Table 1).
Risk of bias in included studies
The risk of bias for individual studies is reported in the
Characteristics of included studies table. Overall the studies were
of reasonable quality with low risk of bias though consideration
of contamination of control patients was generally inadequate.
Allocation concealment was done in six of the ten studies
(Boult 2011, Gitlin 2006; Hogg 2009, Katon 2010, Krska 2001,
Sommers 2000) but was unclear in the remainder. Baseline mea-
surement of outcomes was carried out in all studies. All reported
adequate follow-up of participants except Lorig 1999 who did not
provide specific details for the multimorbidity subgroup, though
follow up for the overall study was adequate. Objective outcomes
were used in all studies except Krska 2001 and Hogg 2009, where
this was unclear. Krska 2001 used a measure detailing pharmaceu-
tical care issues (PCIs) which was a previously developed classifica-
tion system modified for the study. Hogg 2009 collected data on
chronic and preventive care delivery from patient records but there
was no reporting of assessment of this process. Blinding of out-
come assessment was done in six studies (Boult 2011, Gitlin 2006,
Hocchalter 2010, Katon 2010, Lorig 1999, Sommers 2000). It
was unclear in three studies (Bogner 2008, Eakin 2007, Hogg
2009) and not done in Krska 2001.
Only two of the ten studies had a cluster design ensuring no
contamination of control patients (Boult 2011, Sommers 2000).
Contamination of control patients was unlikely in a further four
studies where the intervention was directed at patients rather than
providers ( Eakin 2007, Gitlin 2006, Lorig 1999 and Hocchalter
2010) but was possible in the remaining studies (Bogner 2008,
Hogg 2009, Katon 2010, Sommers 2000). However, Katon 2010
et al provided an additional appendix outlining consideration of
potential contamination and indicated it was minimal and if it had
occurred, would have diluted rather than increased the significant
effect size of their intervention.
The two cluster randomised controlled trials (Boult 2011;
Sommers 2000) had accounted for clustering effects in their anal-
ysis so there were no unit of analysis errors.
Effects of interventions
Effects by type of interventions
As outlined above the interventions were either organisational or
patient oriented. It must be stressed that as all interventions were
complex and multi-faceted, there are overlapping elements across
these two divisions. We have summarised the results by interven-
tion type in Table 2.
The results indicate that organisational type interventions that
are targeted at specific risk factor management or focused areas
where patients have difficulties, such as with functional ability or
medicines management, are more likely to be effective. Organisa-
tional interventions that have a broader focus such as case man-
agement or changes in care delivery seem less effective. Patient
oriented interventions that are not linked to healthcare delivery
seem less effective although there was one exception, Gitlin 2006,
which found significantly reduced mortality following a focused
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intervention targeting functional difficulty and fall prevention (Int
(n= 160): (0.056) Con (n= 159): (0.132), Absol diff 7.6%, Rel%
diff 58%).
Organisational interventions
Six studies had organisational type interventions (Bogner 2008;
Boult 2011; Hogg 2009; Katon 2010; Krska 2001; Sommers
2000). These predominantly involved case management and co-
ordination of care or the enhancement of skill mix in multidisci-
plinary teams.
1. Physical health outcomes
Bogner 2008 and Katon 2010 reported statistically significant im-
provements in blood pressure, though this was of minimal clinical
significance in Katon 2010. Katon 2010 also reported statistically
significant improvements in HBa1c and LDL cholesterol. The
composite primary outcome in Katon 2010 included these three
physical health outcomes combined with the depression score and
was also significantly improved by the intervention. Hogg 2009
also reportedHBA1c and blood pressure for patients who had dia-
betes (62 of 241) and/or hypertension (167 of 241) and found no
significant difference following their intervention. Sommers 2000
reported symptom scores relating to physical health and found no
differences in symptom scores (see Table 3).
2. Mental health outcomes
Three studies presented data on mental health outcomes (Bogner
2008, Katon 2010, Sommers 2000). Two showed significant
improvements in outcomes, all of which related to depression
(Bogner 2008, Katon 2010), whereas Sommers 2000 reported no
difference in depression scores (see Table 4).
3. Psychosocial outcomes
Four studies reported psychosocial outcomes (Hogg 2009, Katon
2010, Krska 2001, Sommers 2000). Krska 2001 stated that SF36
scores had been analysed across eight domains at study completion
and showed no difference between groups, but did not present ac-
tual data. Katon 2010 found significant improvements in HEQol
scores following their intervention. Sommers 2000 found no sig-
nificant differences in SF36 scores or HAQ scores, but did find
significant improvements in social activities counts in the inter-
vention group (see Table 5).
4. Utilisation of health services
Five studies reported outcomes onhealth services utilisation (Boult
2011, Hogg 2009, Katon 2010, Krska 2001, Sommers 2000).
Sommers 2000 reported significant improvements for interven-
tion group patients across a variety of measures relating to hospital
admissions, whereas Boult 2011, Hogg 2009, Katon 2010 and
Krska 2001 found no significant difference in admission related
outcomes, though numbers of admissions in most of these studies
were very small.
Three studies reported data in relation to health service visits with
a range of providers (Boult 2011, Hogg 2009, Sommers 2000)
none of which showed predominantly significant improvements
in health service use (see Table 6).
5. Patient behaviour
5.1 Medication use and adherence
Only one study reported measures relating to medication use and
adherence. Bogner 2008 found significant improvements in pro-
portions of intervention patients adhering to both antidepressant
and antihypertensive medication as measured using automated
counting systems in the caps of medicine bottles (MEMS caps)
(see Table 7).
5.2 Health related behaviours
Two studies provided data on a variety of outcomes relating
to health behaviours by patients (Katon 2010, Sommers 2000).
Katon 2010 found no difference in relation to adherence to diet
and exercise. Sommers 2000 found no significant changes in a
nutrition checklist score (see Table 8).
5. Provider behaviour
Prescribing
Two studies reported measures relating to practitioner prescribing
or medicines management, both of which indicated significant
benefits for intervention patients. Katon 2010 reported a measure
examining one or more medication adjustments for five classes of
drugs related to the co-morbid conditions being studied and found
statistically significant differences for four of these five groups.
Krska 2001 reported a significant reduction in pharmaceutical care
issues in intervention patients which would have been mediated
by changes in both pharmacist intervention and GP prescribing.
Other provider behaviours
Provider behaviours relating to chronic disease management or
preventive care were reported in two studies. Boult 2011 presented
a validated measure called the Patient Assessment of Chronic Ill-
ness Care (PACIC) score, which is a patient assessment of the
quality of care received. This score includes five elements and the
aggregate quality score derived was significantly improved in the
Guided Care intervention group. Hogg 2009 reported measures
relating to chronic disease management and preventive care based
on chart data and both were significantly improved in the inter-
vention group (see Table 9).
6. Acceptability of services
Only two studies reported treatment satisfaction. Katon 2010 re-
ported the proportion of patients moderately to very satisfied with
treatment for depression and diabetes and heart disease at study
completion. Significantly more intervention patients were satis-
fied with their care at study completion compared to those experi-
encing usual care. This was 86% for diabetes or heart disease care
and 90% for depression care for intervention patients, compared
with 70% and 55% respectively for control patients.
Boult 2011 also reported on the changes in satisfaction for
providers as part of an overall examination of the effect of the in-
tervention on providers. (Boult 2008) The measure incorporated
changes in 11 domains of satisfaction with service provision; five
domains relating to time spent with patients; six domains relating
to provider knowledge of the patient, and four domains relating
to care coordination. The only significant changes reported in the
study were improvements in 5 of the 11 domains relating to sat-
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isfaction with service provision.
7. Costs
Four studies provided data on costs (Boult 2011, Katon 2010,
Krska 2001, Sommers 2000).
Leff 2009 et al provided initial cost data from Boult 2011 and
indicated a saving related to Guided Care of $75,000 per guided
care nurse [95% CI -$244,000 to $150,900] or $1364 per pa-
tient. However, these initial results were based on non-significant
changes in outcomes and thus have wide confidence intervals. In
addition, the final study results were subsequently published and
indicated no significant intervention effect.
Katon 2010 reported the direct mean medical costs relating to
the TeamCare intervention over a 12 month period as $1224 per
patient. This study reported on an effective intervention and a full
economic analysis is awaited.
Krska 2001 reported the mean medicine cost for the intervention
and control groups at study completion and found amarginal ben-
efit for the intervention, but this was not statistically significant.
Sommers 2000 reported a net saving per intervention patient of
$90 though this did not include additional savings from fewer
physician visits. It also excluded the costs of implementing the
intervention, stated to be $118,950, mainly relating to salary costs
(see Table 10).
Patient oriented intervention
Four studies had predominantly patient oriented interventions,
as defined in the background section (Eakin 2007; Gitlin 2006;
Hocchalter 2010, Lorig 1999). All four aimed to address patient
health related behaviour and did not engage or intervene with
health care providers directly. The results from these four studies
were mixed and do not suggest that all patient oriented interven-
tions are generally effective. However, the striking findings relat-
ing to mortality from one study were noteworthy, though must be
interpreted with caution, as this was the only study in this review
with such a finding (Gitlin 2006).
1. Physical health outcomes
Eakin 2007 included a sub-group of 175 urban Latino patients
with at least two chronic conditions, and a health educator de-
livered a 16 week diet and physical activity intervention. This in-
volved two face to face visits, three follow up phone calls, and three
newsletters. At sixmonth followup, there weremixed results across
three outcomes reported with significant improvements in dietary
behaviour and support for healthy lifestyle, but no improvement
in physical activity.
Gitlin 2006 produced a followup paper looking at long tem effects
of their intervention on mortality and found significantly reduced
mortality in intervention patients, which persisted up to three and
half years post intervention (Gitlin 2009).
2. Mental health outcomes
One study presented data onmental health outcomes (Lorig 1999)
and found no difference in cognitive symptom management be-
tween groups at study completion (see Table 4).
3. Psychosocial outcomes
Four studies reported psychosocial outcomes (Eakin 2007, Gitlin
2006, Hocchalter 2010, Lorig 1999). Hocchalter 2010, Eakin
2007, and Lorig 1999 found no significant differences in a range
of psychosocial measures. Gitlin 2006 reported six psychosocial
measures by presenting difference in adjusted means between in-
tervention and control groups at follow up and only two showed
significant improvement (self-efficacy in relation to fear of falling
and improvements in control oriented strategies). ADLs, IADLs,
overall functional self-efficacy, and presence of home hazards were
not significantly different (see Table 5).
4. Utilisation of health services
One study reported outcomes on health services utilisation (Lorig
1999) and reported significant improvements for intervention
group patients across a variety of measures relating to hospital ad-
missions. Lorig 1999 also reported on doctor and Emergency De-
partment but found no significant improvements (see Table 6).
5. Patient behaviour
5.1 Medication use and adherence
No study with a patient oriented intervention reported on medi-
cation use and adherence.
5.2 Health related behaviours
Two studies provided data on a variety of outcomes relating to
health behaviours by patients (Eakin 2007, Lorig 1999). Eakin
2007 reported significant improvements in diet behaviour scores
and in changes in minutes of walking per week. Lorig 1999 found
no significant differences in exercise measures or communication
with doctors (see Table 8).
5. Provider behaviour
Prescribing and other provider behaviours
Nostudywith a patient oriented intervention reported on provider
behaviour.
6. Acceptability of services
No study with a patient oriented intervention reported on accept-
ability of services.
7. Costs
Two studies provided data on costs (Gitlin 2006, Lorig 1999).
Gitlin 2006 reported the direct costs associated with the inter-
vention at $1222 per experimental participant. This incorporated
$439 equipment costs and $783 therapy costs.
Lorig 1999 reported the mean direct cost of running the course
for participants who completed it, though costs did not include
the cost of accomodation as this was donated to the study. The
significant reduction in hospital admissions shown by the inter-
vention translated to a saving in healthcare costs per participant
of $750 which the authors point out is ten times the cost of the
intervention. This calculation was based on a presumed cost of
$1000 per day if admitted to hospital (see Table 10).
Comorbidity vs multimorbidity studies
Two of the ten included studies focused on comorbidity rather
thanmultimorbidity in general (Bogner 2008, Katon 2010). Table
2 presents the results across the range of outcomes and compares
effects between these co-morbidity studies and the general multi-
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morbidity studies. The co-morbidity studies showed more signif-
icant effects and were able to use more disease focused interven-
tions and outcome measures.
D I S C U S S I O N
Summary of main results
We identified ten studies eligible for inclusion in the review, all of
which were randomised controlled trials with a generally low risk
of bias. Even within this small number of studies, there was signif-
icant variation in participants and interventions. In two studies,
the focus was on co-morbid conditions, meaning interventions
could be directed at these pre-specified conditions. In the other
studies, which included patients with multimorbidity, the focus
tended to be on older patients and the interventions had multiple
components incorporating different elements, making compari-
son between studies and between intervention elements difficult.
We categorised the intervention components using the EPOC tax-
onomy and identified the predominant intervention element for
each study. When examining the effectiveness of interventions by
intervention type, we concluded that organisational type interven-
tions that are targeted at specific risk factor management or fo-
cused areas where patients have difficulties, such as with functional
ability or medicines management, are more likely to be effective.
Organisational interventions that have a broader focus, such as
case management or changes in care delivery, seem less effective.
Patient oriented interventions that are not linked to healthcare
delivery also seem less effective apart from one study (Gitlin 2006)
which found significantly reduced mortality following a focused
intervention targeting functional difficulty and fall prevention.
We have also presented results by outcomes pre-specified in the
protocol. In general these results were mixed and inconclusive,
particularly those relating to physical health outcomes. In fact,
there was not a strong focus on physical health measures and this
may reflect the challenge in research in multimorbidity when dis-
ease specific measures cannot be used, unless there is more of a
comorbidity focus as in the hypertension/depression or diabetes/
CHD/depression studies in this review.
There was limited effect on psychosocial outcomes and on out-
comes relating to health service utilisation with mixed effects on
hospital admission rates. Outcomes relating to prescribing, med-
ication use, and adherence were measured in three studies and
all found significant benefits. However, the studies may be too
short for these benefits to translate into improvements in physical
health outcomes. Five studies reported patient health behaviours
outcomes and only one showed benefit.
Costs were presented in five studies but data was provided on
direct costs only. The results relating to improved prescribing and
risk factor management, particularly in the co-morbidity trials,
indicate a potential for these interventions to reduce health service
costs over longer periods of time.
Overall completeness and applicability of
evidence
Most of the studies in this review are relatively recent reflecting
the fact that this is a new area conceptually and that research to
date has focused on description and impact rather than interven-
tions. Earlier studies tended to focus on co-morbidity rather than
multimorbidity in general. Two of the studies in this review had
interventions that focused on co-morbid conditions and the sig-
nificant improvements in outcomes is likely related to the strong
focus in these interventions on targeting the specific conditions
involved. It is more challenging to design interventions for people
with a broad range of conditions. The studies that seem more ef-
fective in this group are those which had interventions targeted at
specific areas of concern for patients with multimorbidity, such as
medicines management and functional ability. One of the more
recent studies involved a large well-designed and executed RCT
of a broad organisational type intervention targeted at high risk
individuals with multimorbidity, which found no significant ben-
efit overall (Boult 2011). However, a pre-planned sub-group anal-
ysis indicated significant improvements in the use of some health
services in the patients enrolled in one of the participating care
plans (Kaiser-Permanente, n= 365, 43% of full sample). Boult
2011 postulated that this may have related to the fact that care
was already more organised and structured in this system, so that
Guided Care may simply have extended the existing approaches
used in that setting wheras its implementation was more challeng-
ing in less organised systems. However, the results of sub-group
analysis, even when pre-planned need to be interpreted with cau-
tion given the relatively small samples sizes involved. Nonetheless,
the differences in these sub-groups highlight the importance of
the healthcare delivery setting into which new interventions are
added. Indeed, some of the patient oriented interventions seemed
to run independently of patients’ healthcare delivery, and most
of these studies had limited effectiveness, highlighting the impor-
tance of considering the overall patient experience and integrating
interventions into the healthcare system. The results of the patient
oriented intervention studies are consistent with the Foster 2007
Cochrane review on lay led self-management support programme
which concluded that there is no evidence that these interventions
improve psychological health, symptoms or health-related quality
of life, or that they significantly alter healthcare use.
The evidence from this review partially addresses the review ques-
tion, i.e, what interventions can effectively improve outcomes in
patients with multimorbidity. Interventions need to be targeted
at populations with defined combinations of common conditions
such as diabetes and depression or arthritis and heart disease or
need to focus on targeted problems in multimorbidity popula-
tions, for example, management of multiple medications. How-
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ever, even when interventions are targeted they may not be effec-
tive. The Haynes 2008 Cochrane review of Interventions for en-
hancingmedication adherence concludes that “currentmethods of
improving adherence for chronic health problems are mostly com-
plex and not very effective” and suggests further research is needed.
Patients with multimorbidity may have more specific problems
with medicines use that relate to polypharmacy and managing
complex drug treatment regimens, so medicines management in-
terventions targeting these specific difficulties may be more effec-
tive.
As research in this area is increasing and a number of ongoing
studies have been identified, we anticipate that the next update of
the review will provide better evidence to inform policy makers
and those planning services for individuals with multimorbidity.
Quality of the evidence
All of the included studieswere randomised controlled trials.Over-
all they were of reasonable quality with minimal risk of bias, al-
though consideration of contamination of control patients was oc-
casionally inadequate. Multimorbidity is a complex area because
participants can vary depending on definitions used. This limits
the potential to reasonably combine study results for meta-analy-
sis, and potentially limits the internal validity of the results of the
review.
Potential biases in the review process
The review was carried out in accordance with EPOC guidelines
and using the updated Cochrane Handbook. Potential limitations
in the search process relate to the lack of a MeSH term for mul-
timorbidity. This meant that we had to use broad search terms
which led to a high yield of citations to be searched. However, the
authors are active researchers in the field of multimorbidity and
are unaware of any potentially eligible studies that were missed
by the search. We were also unable to retrieve some missing data
from authors. However, as no meta-analysis was undertaken this
did not lead to any appreciable measurement bias.
Agreements and disagreements with other
studies or reviews
We were unable to group sufficient numbers of studies with sim-
ilar interventions in order to comment on which elements of in-
terventions (e.g. the use of community pharmacists) seemed most
effective and compare our review to other reviews of these inter-
ventions. The most consistent intervention element across all in-
cluded studies was the use of case managers, but even these var-
ied in that some were clinical case managers and others were ad-
ministrative managers. The Cochrane review of the effect of case
management on health care outcomes is ongoing but does plan to
address differences in effectiveness between different types of case
management.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Multimorbidity is common in clinical practice and there is limited
evidence supporting specific interventions. The focus of an inter-
vention will be different for a patient under or over 65, and the
outcomes chosen should reflect this. Most of the multimorbidity
studies in this review focused on older patients; however, it is im-
portant to address the needs of younger patients also as there are
issues relating to employability and absenteeism. Acting upstream
for younger patients withmultimorbidity is preventive and has po-
tential to bring about significant quality of life benefits for individ-
uals as well as cost savings for healthcare systems. However, even
in ageing populations, multimorbidity worsens outcomes so there
is still likely to be room for improvement, at least in ambulatory
care patients. This review suggests that targeting specific problems
experienced by patients with multimorbidity may be more effec-
tive. We also need to recognize the importance of socioeconomic
status and the impact of deprivation. Recent work in Scotland has
highlighted that individuals in the poorest socioeconomic groups
are more likely to develop multimorbidity at a younger age and
more likely to die prematurely as a result (Barnet 2011).
The sub-group analysis from the Guided Care study suggests that
multimorbidity interventions need to be integrated into existing
healthcare systems for reasons of sustainability (Boult 2011). Inde-
pendent interventions that do not integrate with existing health-
care systems will have difficulty with sustainability. Many of the
included studies focused on integration of care between practi-
tioners, but we also need to consider how we integrate interven-
tions into healthcare systems.
The literature on multimorbidity indicates that it is generally as-
sociated with poorer outcomes for patients. However, it may be
worth prioritising which outcomes should be addressed in an in-
tervention. This should be addressed in the early stages of the de-
velopment of a potential new intervention and we should focus
on eliciting patients’ values and preferences. Patients with multi-
morbidity are not only at higher risk of many adverse outcomes,
but they also have competing outcomes. The more complex the
case, the more we should think in terms of outcomes that are
relevant across diseases, e.g, nutrition, living situations, function,
symptom burden, survival, and active life expectancy. Having the
patient participate in priority setting based on his/her values and
preferences becomes both the rational and the ethical thing to do.
Within this review, interprofessional collaboration was embedded
in all interventions. This is worth building on for future inter-
vention development. Most of the included studies focused on
changing professional care provision; it may also be worthwhile
incorporating the patient perspective. This could be achieved by
adopting a participatory approach to intervention development.
Patientswithmultimorbidity, their familymembers, and a range of
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professionals involved should be consulted during the modelling
and exploratory phases of service and intervention planning.
Implications for research
Definitions
There is a need for a clear conceptual definition of multimorbid-
ity and its differentiation from other related concepts such as co-
morbidity, complexity, frailty, and vulnerability. We need specific
measures to accurately classify patients. This will be particularly
important given the need to account for the heterogeneity of mul-
timorbidity; interventions could have differential effects depend-
ing on the definition or degree of multimorbidity and the socioe-
conomic status of participants.
Without these definitions and consideration of related concepts,
the generalisability or applicability of studies for patientswithmul-
timorbidity (with a broader definition than only two or three fixed
diseases) will be uncertain, as is the case for many of the studies in
this review, particularly those with the specific co-morbidity focus.
We would also advocate for including multimorbidity as a MeSH
term as the search strategy for this review and for ongoing work
on multimorbidity is particularly complex and time consuming,
given the growing concern and interest in the issue.
Study design
While the risk of bias was generally low in this review and all stud-
ies were RCTs, we acknowledge the difficulty of conducting op-
timal RCTs due to the heterogeneity of multimorbidity. So prag-
matic trials or sequential RCTs may also be appropriate while still
maintaining rigour.
Future studies need to carefully consider the comparison or con-
trol group, particularly in relation to contamination of control
patients. Cluster randomised designs are likely to be optimal if
interventions are delivered through care providers. This needs to
be taken into account both in terms of power calculations and in
the analysis of results.
Interventions
This review indicates that interventions that are targeted at either
specific combinations of common conditions, or at specific prob-
lems for patients with multiple conditions, may be more effective.
When designing interventions researchers should be clear about
the theoretical assumptions underlying the intervention, consider
its individual components and the evidence base behind each and
then link these to outcomes as outlined below. They should also
consider interventions that are likely to be reproducible and ap-
plicable within the context of primary care. TheMedical Research
Council Framework for the Design and Evaluation of complex
interventions designed to improve health, provides useful guid-
ance in designing and undertaking these trials. (MRC Framework
2008)
The majority of the evidence for effective chronic disease man-
agement has been based on a single disease paradigm. However, it
is likely that participants in these trials had some degree of mul-
timorbidity, though sicker patients may have been excluded. We
should therefore seek to build on and apply the evidence regard-
ing effective interventions for single conditions to patients with
multimorbidity, rather than designing interventions with no con-
sideration of the existing evidence base for single conditions.
In its broadest sense, multimorbidity encompasses a large variety
of patients which must be considered as it is not pragmatic to
design interventions that change systems completely. For this rea-
son, parallel economic analyses that link outcomes to costs and
benefits are better than providing simple cost data alone, which
make comparison across studies difficult.
Outcomes
The challenge with multimorbidity is to define a set of outcomes
that can be used for different combination of diseases, so there
is a need for generic outcomes measures that incorporate physi-
cal functioning and quality of life that are responsive to change
over time. Other outcomes to consider include goal attainment,
self-care, self efficacy, health related quality of life, distress, adher-
ence to treatment, behavioural changes regarding health habits,
patient’s knowledge about care plans, shared decision making, and
participation in care. However, unless validatedmeasures are used,
many of these outcomes will not be comparable across studies.
The recent work of PROMIS (PROMIS 2011) provides validated
and useful patient reported outcomes that will be particularly rel-
evant for those researching interventions to improve outcomes for
patients with multimorbidity.
Most of the interventions in this review used a conceptual model,
particularly the Chronic Care Model. The outcomes chosen
should also reflect the theoretical underpinning as to how and why
the intervention might work. It would also be helpful if authors
clearly identified intervention elements and matched outcomes to
these elements in an effort to clarify which components of multi-
faceted interventions are more effective than others.
Conclusion
This review highlights the paucity of research into interventions to
improve outcomes for multimorbidity with the focus to date be-
ing on co-morbid conditions or multimorbidity in older patients.
It indicates that interventions that are targeted at either specific
combinations of common conditions, or at specific problems for
patients with multiple conditions, may be more effective. How-
ever, further research is needed and future interventions should be
developed in ways that allow rigorous evaluations to be performed
that will add to the evidence. There is a need for clear and broader
definitions of participants, consideration of appropriate outcomes,
and further pragmatic studies based in primary care settings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bogner 2008
Methods Randomised controlled trial
USA
Participants 64 patients aged 50 years and older with hypertension and depression (defined as a
diagnosis of depression or prescription of antidepressant within the past year)
Integrated care manager and 12 family physicians in primary care clinic
Interventions Integration of depression and hypertension treatment coordinated by integrated care
manager; individualised programcomprising three 30 minute in-person sessions with
patients and two 15 minute follow up phone calls
Outcomes Depression scores (Centre for Epidemiological Studies depression scale (CES-D)); Blood
pressure; per cent adherent to antidepressant medication; per cent adherent to antihy-
pertensive medication (adherence measured using electronic measuring devices (MEMS
caps))
> or = 80% adherence to antidepressant
Notes Intervention lasted 6 weeks and follow up 2 weeks later
Controls received usual care
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Paper states “patients were randomly assigned”
Allocation concealment (selection bias) Unclear risk Not stated in text
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Automated measurement devices were used but au-
thors don’t specifically state that outcome assessors
were blinded
Protection against contamination Low risk 25% control consultations monitored to check for
contamination
Reliable primary outcomes Low risk Validated measures and automated tests
Follow up of patients Low risk 100% follow up
Baseline measurement Low risk Groups comparable at baseline
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Boult 2011
Methods Cluster randomised controlled trial
USA
Participants 904 patients aged 65 years or more with history of high service use and multiple medical
conditions, covered by Medicare or other insurance
8 practices with 49 primary care practitioners (PCPs); 7 Guided Care nurses (GCNs)
Arranged in ’pods’ of 1 GCN, 2-5 PCPs and 50-60 patients
Interventions ’Guided Care’ programme comprising eight clinical services including home based as-
sessment, individual management plan, coaching for self-management with monthly
monitoring and coordination of care provision
Delivered by trained GCNs
Outcomes PACIC (Patient assessment of chronic illness care) score; Health service use
Health care costs (6 months data only available)
Notes Intervention duration 18 months; follow up at 6 and 18 months
Controls received usual care with PCPs
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation
Allocation concealment (selection bias) Low risk Carried out independently by study statisti-
cian
Blinding (performance bias and detection
bias)
All outcomes
Low risk Interviewers blinded to group allocation
Protection against contamination Low risk Cluster design
Reliable primary outcomes Low risk Validated measures
Follow up of patients Low risk >90%
Baseline measurement Low risk Groups comparable at baseline
Eakin 2007
Methods Randomised controlled trial
USA
Participants Sub-group of 175 Urban Latinos with multimorbidity (defined as two or more chronic
conditions) (data on sub-group directly from authors)
Bilingual health educator
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Eakin 2007 (Continued)
Interventions Diet and physical activity intervention with self-management support delivered by a
health educator; involving two face to face visits (60-90 mins) three months apart; three
follow up phone calls and three newsletters
Outcomes Physical activity (Behavioural Risk Factor Surveillance Survey Physical Activity scores);
dietary behaviour (Kristal Fat and Fiber Behaviour (FFB) questionnaire); Chronic Illness
Resource Survey (CIRS)
Notes Intervention 16 weeks, follow up 6 months post intervention
Control group received usual care plus a guide to local services and three newsletters
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated scheme
Allocation concealment (selection bias) Unclear risk Sequentially numbered envelopes used - unclear if
were opaque
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not stated in text
Protection against contamination Low risk Not a cluster design but authors state that providers
not involved in intervention delivery and intraclus-
ter correlation coefficients low previously in this
population
Reliable primary outcomes Low risk Validated measures used
Follow up of patients Low risk 80% follow up
Baseline measurement Low risk Groups comparable at baseline
Gitlin 2006
Methods Randomised Controlled Trial USA
Participants 319 patients aged 70 years or more with reported difficulties with at least one activity of
daily living
Interventions Multicomponent home intervention (the ABLE programme) delivered by occupational
therapist (OT) and physical therapist (PT) targeted at reducing functional difficulties;
involving five OT contacts (4 face to face for 90 minutes and 1 telephone) and one PT
visit (90 minutes) over 6 months followed by 6 month follow up with 3 telephone calls
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Gitlin 2006 (Continued)
and final home visit
Individual priorities identified and strategies such as problem solving, balance andmuscle
strengthening and fall recovery techniques with use of environmental adjustments where
needed
Outcomes Activities of Daily living (ADLs and IADLs), self-efficacy relating to falls (Falls Efficacy
Scale), overall functional self-efficacy, control oriented strategies and presence of home
hazards (home hazard index)
Mortality (NDI records were obtained for death)
Notes Intervention lasted 12 months (first 6 months intensive phase followed by second six
months telephone contact and final closure visit); data collection at 12months; mortality
data collection 4 years later
Usual care comparator with control patients receiving a leaflet on home safety at study
completion
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation done by project statistician,
Allocation concealment (selection bias) Low risk “Randomization lists and four sets of randomi-
sation were prepared using double, opaque en-
velopes”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “trained interviewers who were masked to group
assignment and study hypotheses and who had no
role in the intervention interviewed them at 6 and
12 months.”
Protection against contamination Low risk Control group had no access to intervention
Reliable primary outcomes Low risk Self-report outcomes but all validated
Follow up of patients Low risk 12 month follow up 89%
Baseline measurement Low risk Groups comparable at baseline
Hocchalter 2010
Methods Randomised controlled trial
USA
Participants 79 patients aged 65 or older with at least two of seven qualifying chronic illnesses who
had received treatment in previous 12 months
Primary health care providers in “large Internal Medicine Clinic” in Medical School
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Hocchalter 2010 (Continued)
Teaching Hospital
Interventions Patient engagement intervention: “Making the most of your healthcare” comprising one
2-hour workshop and two follow up phone calls before and after a subsequent routine
medical appointment, delivered by ‘coaches’
Outcomes Primary: Patient activation measure (PAM)
Secondary: Communication with physicians scale; health-related QoL (HRQOL-14);
Self-Efficacy for CDM
Notes Intervention ran during first 3 months after baseline data collection; follow up at 6
months from baseline
Comparison was ’attention control’ - workshop on safety in the home
Study presented as a feasibility study
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only reported as ’randomly assigned’
Blinding (performance bias and detection
bias)
All outcomes
Low risk “interviews carried out by a research assistant
blinded to group assignment”
Protection against contamination Low risk Control group had no access to patient oriented
intervention
Reliable primary outcomes Low risk Valid measures used
Follow up of patients Low risk 81% follow up
Baseline measurement Low risk Groups comparable at baseline
Hogg 2009
Methods Randomised controlled trial
Canada
Participants 241 patients aged 50 years or older with at least two chronic conditions and at risk of
experiencing adverse health outcomes
8 Family Practitioenrs; 5 nurses and 11 administrative staff in one family health network
in rural Ontario
Interventions APTCare Intervention:
Home-based multidisciplinary team management with an initial; assessment by a nurse
practitioner and a medication review by pharmacist and individualised patient care plan
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Hogg 2009 (Continued)
Outcomes Primary: Chronic disease management score (CDM score) based on 12 indicators for
one of four chronic diseases
Secondary outcomes: Clinical outcomes where applicable: BP and Hba1c;
quality of preventive care using 6 preventive indicators from the Canadian Task Force
on Preventive Health Care (Quality of preventive care score); health related QOL scores
(SF36); instrumental activities of daily living (IADL score); and health service use (hos-
pitalisation, ED visits)
Notes Intervention duration 15 months, follow up at intervention completion
Controls received usual care
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Done centrally through automated telephone
system
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear for primary outcome, reported as done
for secondary outcomes
Protection against contamination Unclear risk Potential contamination as not cluster ran-
domised
Only intervention patients received intervention
but FPs and existing nurses could have modified
their behaviour with control patients based on
their experience with intervention patients
Reliable primary outcomes Unclear risk Unclear for primary outcome
Required chart review which was carried out
by a physician, where the data was not clearly
recorded in the chart, a nurse double checked
and they reached agreement
No reporting of assessment of process
Follow up of patients Low risk 95% follow up
Baseline measurement Low risk Groups comparable at baseline
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Katon 2010
Methods Randomised controlled trial
USA
Participants 214 patients with depression and diabetes and/or coronary heart disease
Primary Care Practitioners (PCPs) in 14 primary care clinics and 3 trained medically
supervised nurses
Interventions TEAMcare intervention integrating a treat-to-target programme with structured visits
with nurses, individualised care plans and treatment targets, support for self-care com-
bined with pharmacotherapy, provision of self-care materials for patients, weekly meet-
ings to discuss case progression between nurses, PCPs, psychiatrist and psychologist,
electronic registry used to track patient risk factors and depression scores
Outcomes Primary outcome: Composite measure of risk factor control incorporating HBA1c; LDL
cholesterol, SBP and scores on the SCL-20 depression scale
Secondary outcomes: SCL-20 depression scores; patient global rating of improvement
score (i.e. >50% improvement in SCL-20 score); medication adjustments; medication
adherence; adherence with diet and exercise plans; quality of life and satisfaction with
care
Notes Control group had “Enhanced primary care’ i.e. usual care plus PCPs informed of de-
pression diagnosis and of results at baseline, 6 and 12 months; intervention duration 12
months; follow up data collection at 12 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomly assigned by a centrally randomised pro-
cess”
Allocation concealment (selection bias) Low risk Carried out centrally
Blinding (performance bias and detection
bias)
All outcomes
Low risk “research assistants who were unaware of the inter-
vention status implemented study procedures”
Protection against contamination Unclear risk Control group did not have access to study nurses
butmanagedby same groupof PCPs as intervention
group
Reliable primary outcomes Low risk Automated measures or validated scales
Follow up of patients Low risk 12 month follow up > 83% all measures, majority
> 90%
Baseline measurement Low risk Comparable groups at baseline
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Krska 2001
Methods Randomised controlled trial
UK
Participants 332 patients aged over 65 years with at least two chronic conditions and taking at least
four prescribed medications regularly; six general practices in Grampian, UK
Interventions Pharmaceutical care plan drawn up by a pharmacist based onmedical records and patient
interviews, and then implemented by the practice team
Outcomes Pharmaceutical care issues (PCI scale); SF36 scores
Health service utilisation including GP and practice nurse contacts, OPD attendance,
use of social services and hospital admissions
Direct monthly costs of prescribed medications per patient
Notes Study duration and follow up 3 months; controls had review of drug therapy by phar-
macist but no pharmaceutical care plan implemented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Text simply states “patientswere randomly allocated”
Allocation concealment (selection bias) Unclear risk Randomisation method not specified
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Protection against contamination High risk Authors state that contamination of control patients
could have occurred but stated that a cluster design
would have been more problematic due to differen-
tial prescribing patterns between practices
Reliable primary outcomes Unclear risk PCIs previously used but unclear whether validated
as outcome measure
Follow up of patients Low risk 87% follow up
Baseline measurement Low risk Some baseline imbalance between groups for PCIs
and admissions; not clinically significant
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Lorig 1999
Methods Randomised controlled trial
USA
Participants Subgroup of 536 patients over 40 years with at least two of the following chronic con-
ditions: heart disease, lung disease, stroke or arthritis; recruited through mass media
Volunteer lay leaders ran weekly group meetings
Interventions Chronic Disease Self Management Programme: weekly meetings for seven weeks deliv-
ered in community settings by trained volunteer lay leaders
Outcomes Self-rated health scale (from the National Health Interview Survey); Health Assessment
Questionnaire (HAQ)disability scale; psychological well-being (MHI-5well-being scale)
; pain and physical discomfort scale (adaptation of theMedical Outcomes Survey (MOS)
pain scale); energy and fatigue scale (MOS energy and fatigue scale) health distress scale
(modified MOS health distress scale); Measures of health behaviour including duration
exercise taken, use of cognitive symptom management, communication with physicians,
social and role activity limitations
Health service utilisation including physician, emergency department and hospital visits
and number nights as hospital inpatient
Direct programme costs and savings
Notes Study duration and follow up 6 months; waiting list controls
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study reports “randomisation was conducted seri-
ally”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors blinded
Protection against contamination Low risk Controls on waiting list so no exposure to those
delivering community based intervention
Reliable primary outcomes Low risk Validated measures used
Follow up of patients Unclear risk Not stated specifically for multimorbidity sub-
group; overall follow up 85%
Baseline measurement Low risk Groups comparable at baseline
27Interventions for improving outcomes in patients with multimorbidity in primary care and community settings (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sommers 2000
Methods Cluster randomised controlled trial
USA
Participants 543 patients older than 65 years with at least two chronic conditions and living inde-
pendently, attending 18 private office practices of primary care physicians
Interventions Senior Care Connections (SCC) intervention delivered by a team including the primary
care physician, a nurse with geriatric medicine training and a social worker
Home visit assessment followed by team discussion and development of a risk reduction
plan and treatment targets
Outcomes Physical functioning (Health activities questionnaire (HAQ)); emotional functioning
(short form geriatric depression scale (GDS)); perceived health status (SF36); social
activities count; symptom scale; medication count and nutrition checklist
Health service utilisation including office, emergency room and home care visits, hospital
admissions, skilled nursing facility admissions, length of hospital stay and nursing home
placements
Direct costs of the intervention
Notes Study duration 2 years, 12 month follow up post completion intervention; controls
received usual care from their primary care physician
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study reports “physicians randomised”
Allocation concealment (selection bias) Unclear risk Unclear at cluster level but no bias at patient
level as recruited through clusters
Blinding (performance bias and detection
bias)
All outcomes
Low risk Healthcare utilisation measured from auto-
mated data.
Protection against contamination Low risk Cluster randomisation
Reliable primary outcomes Low risk Automated data used and validated mea-
sures used
Follow up of patients Low risk 86% follow up for service use measures;
74% follow up questionnaire data
Baseline measurement Low risk Groups comparable at baseline
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Addolorato 2004 Specialist setting
Brand 2004 Specialist setting
Dorr 2008 No appropriate data for sub-group with multimorbidity
Drake 1998 Specialist setting
Essock 2006 Specialist setting
Harpole 2005 Intervention not based on multimorbidity: the study presents an analysis of whether co-morbidity alters response
to a depression intervention
Hien 2004 Specialist setting
Katon 2004 Intervention directed at one condition only (depression)
Leveille 1998 Participants not defined as having multimorbidity as per review protocol
Lewis 2008 Study design ineligible
Lin 2003 Intervention directed at one condition only (depression)
Lyles 2003 Participants had medically unexplained symptoms, not multimorbidity
Morey 2006 Participants defined as having a range of chronic conditions (from 0-15) with no sub-group eligible for inclusion
in this review
Rucker-Whitaker Study design ineligible
Schneider 2008 Study design and intervention ineligible
Van Eijk 2004 Pilot study only with no follow up
Zhang 2008 Did not meet EPOC criteria for study design
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Characteristics of ongoing studies [ordered by study ID]
Rosenman 2006
Trial name or title The Indiana Chronic Disease Management Program
Methods Randomised Controlled Trial (cluster)
Participants State-wide programme
Interventions Seven components: (1) identification of eligible participants to create regional registries, (2) risk stratification
of eligible participants, (3) nurse care management for high risk participants, (4) telephonic intervention for
all participants, (5) an internet-based information system, (6) quality improvement collaboratives for primary
care practices, and (7) program evaluation
Outcomes Health service utilisation; costs; disease outcomes such as HBA1c for diabetes
Starting date July 1st 2003
Contact information mrosenman@iupui.edu
Notes
Schraeder 2005
Trial name or title Managing elders with comorbidities
Methods Prospective, longitudinal randomised treatment-control design
Participants 677 patients aged 65 and older judged to be ’high risk’
Interventions Primary care based nurse case management
Outcomes Health care utilisation
Starting date unclear
Contact information cheryls@uic.edu
Notes
Van Bastelaar 2008
Trial name or title Web-based cognitive behavioural therapy (W-CBT) for diabetes patients with co-morbid depression
Methods Randomised controlled trial
Participants 286 patients
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Van Bastelaar 2008 (Continued)
Interventions 8-week, moderated self-help course tailored to the needs of persons living with diabetes and offered on an
individual basis Participants receive feedback on their homework assignments by e-mail from their coach
Outcomes Primary outcomes are depressive symptoms and diabetes-specific emotional distress. Secondary outcomes are
satisfaction with the course, perceived health status, self-care behaviours, glycaemic control, and days in bed/
absence from work
Starting date Protocol published in 2008
Contact information k.vanbastelaar@vumc.nl
Notes
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Intervention elements
Intervention element Study
(Predominant element of intervention in Bold)
1. Professional
Education/ training of care coordinators Boult, Katon, Sommers
2. Financial
3. Patient
Self management support and patient education Eakin, Boult, Gitlin, Katon, Lorig, Hochhalter
Peer support Lorig
4. Organisational
4.1 Provider
Care coordination or management Bognor, Boult, Katon, Sommers
Enhanced multidisciplinary team (e.g. addition pharmacist or so-
cial worker)
Hogg, Katon, Krska, Sommers
4.2 Patient
Individual care plans Bognor, Boult, Gitlin, Hogg, Katon, Krska, Sommers
Enhanced multidisciplinary community care Eakin, Gitlin,
4.3 Structural
Structured visits Eakin, Bognor, Boult, Gitlin, Hogg, Katon, Krska
Structured telephone contact Bognor, Eakin, Gitlin, Hochhalter, Hogg
5. Regulatory
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Table 2. Summary of outcomes
Outcome category Outcome No. studies with this
outcome
Multimorbidity (MM)
Vs
Co-morbidity
(Co-M)*
No. studies with p< 0.
05 for this outcome
Physical Health
(6 studies)
Hb1Ac 2 MM and Co-M 1
BP 3 MM and Co-M 2
Cholesterol 1 Co-M 1
Other symptom score 2 MM 0
Mortality 1 MM 1
Mental Health
(4 studies)
Depression scores 3 MM and 2 Co-M 2
% improved depression 1 Co-M 1
Cognitive symptom
management
1 MM 0
Psychosocial
(8 studies)
QoL/ general health 5 4 MM and Co-M 1
Functional impairment
& disability
4 MM 0
Social (activity/ support) 3 MM 1
Self efficacy 2 MM 1
Home hazards 1 MM 0
Health service use
(5 studies)
Visits/ use service 4 MM and 1 Co-M 0
Hospital admission re-
lated
5 MM and 1 Co-M 2
Patient health related be-
haviours
(5 studies)
Exercise/ diet 5 MM and 1 Co-M 1
Medication adherence
(1 study)
1 Co-M 1
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Table 2. Summary of outcomes (Continued)
Provider behaviour
(4 studies)
Prescribing 2 MM and Co-M 2
Disease management 2 MM 2
Costs Direct costs 5 - Not applicable
* Multimorbidity is defined as two or more independent conditions within the same individual whereas co-morbidity refers to linked
conditions. In this review co-morbidity studies included depression and diabetes or depression and hypertension
** The scales or meaurements used in each study for the outcomes are described in the Table of included studies
Table 3. Physical Health Outcomes
Study Study type Outcomes Results Notes
Bognor RCT Systolic BP Int (n=32): 127.3 (SD 17.7) Con (n=
32): 141.3 (SD18.8) Absol diff 14 Rel
% diff 10%
*
SES = 1.12
Bognor RCT Diastolic BP Int (n=32): 83 (SD 10.7) Con (n=32)
: 81.4 (SD 11.1)
Absol diff 9.2
Rel % diff 11%
*
SES =
0.8
Gitlin RCT Mortality Int (n= 160): (0.056) Con (n= 159):
(0.132)
Absol diff 7.6%
Rel% diff 58%
*
Hogg RCT Systolic BP Int (n= 87): 124.3 Con (n= 80): 124.
2
Absol diff 0.1
Rel % diff <0.1%
ns
Hogg RCT HBA1c Int (n= 36): 7.01 Con (n= 36): 6.78
Absol diff 0.23
Rel % diff 3%
ns
Katon RCT Systolic BP Int (n= 105): 131 (SD 18.4) Con (n=
106): 132.3 (SD 17.2)
Absol diff 1.3
Rel % diff 1%
*
SES = 0.07
Katon RCT HBA1c Int (n= 105): 8.14 (SD 2.03) Con (n=
106): 8.04 (SD 1.87)
Absol diff 0.1
Rel % diff 13%
*
SES = 0.32
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Table 3. Physical Health Outcomes (Continued)
Katon RCT Cholesterol Int (n= 105): 91.9 (SD 36.7) Con (n=
106): 101.4 (SD 36.6)
Absol diff 9.5
Rel % diff 9%
*
SES = 0.26
Lorig RCT Pain/ physical discomfort Int (n= 311) 59.8 (SD 20.1)
Con (n= 225) 60.6 (SD 17.1)
Absol diff 0.8
Rel %diff 1%
SES = 0.04
ns
Lorig RCT Energy/fatigue Int (n= 311): 2.18 (SD 0.73) Con (n=
225): 2.02 (SD 0.75)
Absol diff 0.16
Rel %diff 8%
ns
Lorig RCT Shortness of breath Int (n= 311): 1.34 (SD 0.91)
Con (n= 225): 1.58 (SD 0.83)
Absol diff 0.24
Rel % diff 15%
ns
Sommers RCT Symptom scores Int (n**): 17.2
Con (n**): 18.9
Absol diff 1.7
Rel % diff 9%
ns
* refers to whether original study reported statistically significant improvement in this outcome
** Total number with final data collected was 384. No final numbers of intervention and control patients presented.
Table 4. Mental Health Outcomes
Study Study type Outcome Result Notes
Bognor RCT CES-depression score Int: 9.9 (SD10.7) Con 19.3 (SD
15.2)
Absol diff 9.4
Rel % diff 49%
*
SES = 0.75
Katon RCT SCL 20 depression score Int:0.83 (SD 0.66) Con: 1.14 (SD
0.68)
Absol diff 0.31
Rel % diff 27%
*
SES = 0.46
Katon RCT Patient global improvement in de-
pression
Int: 41/92
Con: 16/91
Absol diff 27%
Rel % diff 150%
*
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Table 4. Mental Health Outcomes (Continued)
Lorig RCT Cognitive symptom management
score
Int: 1.75
Con: 0.98
Absol diff 0.77
Rel % diff 79%
ns
Sommers RCT GDS score (depression) Int: 4.1
Con: 4.1
Absol diff 0
Rel % diff 0%
ns
* refers to whether original study reported statistically significant improvement in this outcome
Table 5. Psychosocial outcomes
Study Study type Outcome Result Notes
Eakin RCT Multilevel support for healthy
lifestyle
Int: 2.7 Con: 2.59
Absol diff 0.11
Rel % diff 4%
ns
Hochhalter RCT Total unhealthy days Int: 15.3 Con: 14.1
Absol diff 1.2
Rel % diff 9%
ns
Hochhalter RCT Self-efficacy Int: 7.4 Con: 8.0
Absol diff 0.6
Rel % diff 7.5%
ns
Hogg RCT Total unhealthy days Int: 7.6 Con: 9.9
Absol diff 2.3
Rel % diff 23%
ns
Hogg RCT SF 36 Mental Health Int: 52.4 Con:52.2
Absol diff 0.2
Rel % diff 0.3%
ns
Hogg RCT SF 36 Physical Health Int: 44.3 Con:41.5
Absol diff 2.8
Rel % diff 6.7%
ns
Hogg RCT IADL Int: 10.6 Con: 10.9
Absol diff 0.3
Rel % diff 2.7%
ns
Katon RCT QoL score Int: 6.0 (SD 2.2) Con: 5.2 (SD 1.
9)
Absol diff 0.8
*
SES = 0.44
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Table 5. Psychosocial outcomes (Continued)
Rel % diff 15%
Lorig RCT Self-rated health Int: 3.42
Con: 3.44
Absol diff 0.02
Rel %diff 0.6%
ns
Lorig RCT Disability Int: 0.86
Con: 0.96
Absol diff 0.1
Rel %diff 10%
ns
Lorig RCT Social role/activity limitation Int: 1.91
Con: 1.98
Absol diff 0.07
Rel %diff 4%
ns
Lorig RCT Psychological well-being Int: 3.47
Con: 3.33
Absol diff 0.04
Rel %diff 4%
ns
SES=0.21
Lorig RCT Health distress Int: 1.97
Con: 2.13
Absol diff 0.16
Rel %diff 7.5%
ns
SES=0.16
Sommers RCT SF36 score Int: 2.2
Con: 3.3
Absol diff 1.1
Rel %diff 33%
ns
Sommers RCT Social activities count Int: 8.7
Con: 8.6
Absol diff 0.1
REl %diff 1%
* (when adjusted
for baseline diff )
Sommers RCT HAQ score Int: 0.44
Con: 0.5
Absol diff 0.06
Rel %diff 12%
ns
* refers to whether original study reported statistically significant improvement in this outcome
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Table 6. Health service use
Study Study type Outcome Result Notes
Boult RCT No. hospital admissions Int: 0.7 Con: 0.72
Absol diff 0.02
Rel % diff 3%
ns
Boult RCT No. days in hospital Int: 4.26 Con: 4.49
Absol diff 0.23
Rel % diff 5%
ns
Boult RCT No. ED visits Int: 0.44 Con:0.44
Absol diff 0
Rel % diff 0
ns
Boult RCT No. PC visits Int: 9.98 Con: 9.88
Absol diff 0.1
Rel % diff 1%
ns
Boult RCT No. specialist visits Int 9.04 Con:8.49
Absol diff 0.55
Rel % diff 6%
ns
Boult RCT No. home healthcare episodes Int: 0.99 Con: 1.3
Absol diff 0.31
Rel % diff 24%
*
Hogg RCT No. hospital admissions Int: 0.4 Con: 0.46
Absol diff 0.06
Rel % diff 13%
ns
Hogg RCT Proportion hospitalised Int: 0.26
Con: 0.26
Absol diff 0
Rel % diff 0%
ns
Hogg RCT No. ED visits Int: 0.63 Con: 0.73
Absol diff 0.01
Rel % diff 14%
ns
Hogg RCT Proportion with ED visit Int: 0.38
Con: 0.42
Absol diff 0.04
Rel % diff 9%
ns
Katon RCT Proportion hospitalised Int: 0.26
Con: 0.22
Absol diff 0.04
Rel %diff 18%
ns
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Table 6. Health service use (Continued)
Lorig RCT No. doctor and ED visits Int: 6.51
Con: 7.08
Absol diff 0.57
Rel %diff 8%
ns
Lorig RCT No. hospital stays in past 6months Int: 0.26
Con 0.31
Absol diff 0.05
Rel %diff 6%
*
Lorig RCT No. nights in hospital in last 6
months
Int: 1.3
Con: 1
Absol diff 0.3
Rel %diff 30%
*
Sommers RCT No. hospital admissions per pa-
tient per year
Int: 0.36
Con: 0.52
Absol diff 0.16
Rel %diff 31%
*
Sommers RCT ≥1 60 day readmission Int 3.6
Con: 9.4
Absol diff 5.8
Rel%diff 62%
*
Sommers RCT ≥ 1 hospital admission Int: 8.8
Con: 7.7
Absol diff 1.1
Rel %diff 14%
*
Sommers RCT No. PCP visits Int: 6.0
Con: 6.1
Absol diff 0.1
Rel %diff 2%
ns
Sommers RCT No. office visits Int: 11
Con: 12.5
Absol diff 1.5
Rel %diff 12%
*
Sommers RCT ≥ 1 home care visit Int: 19.5
Con: 18.8
Absol diff 0.7
Rel %diff 4%
ns
Sommers RCT No. medical specialist visits Int: 1.4
Con: 1.7
Absol diff 0.3
Rel %diff 18%
ns
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Table 6. Health service use (Continued)
Sommers RCT No. other visits Int 3.9
Con: 4.3
Absol diff 0.4
Rel %diff 9%
*
Sommers RCT ≥ 1 ED visit Int: 21.4
Con: 16.7
Absol diff 4.7
Rel %diff
ns
* refers to whether original study reported statistically significant improvement in this outcome
Table 7. Medication adherence
Study Study type Outcome Results Notes
Bognor RCT ≥80%adherence to antidepressant
medication (MEMS caps)
Int: 23/32
Con: 10/32
Absol diff 0.41
Rel %diff 132%
*
Bognor RCT ≥80% adherence to antihyperten-
sive medication (MEMS caps)
Int: 25/32
Con: 10/32
Absol diff 0.47
Rel %diff 152%
*
* refers to whether original study reported statistically significant improvement in this outcome
Table 8. Health related patient behaviours
Study Study type Outcome Results Notes
Hochhalter RCT PAM (patient activation mea-
sure)
Int: 66.8 Con: 66.2
Absol diff 0.6
Rel % diff 1%
ns
Eakin RCT Diet behaviour scores Int: 2.2 Con: 2.41
Absol diff 0.21
Rel % diff 9%
*
Eakin RCT Change minutes of walking/week Int: +8
Con: -10
Absol diff 18
Rel % diff 180%
*
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Table 8. Health related patient behaviours (Continued)
Katon RCT General adherence to diet score Int:0.86 Con: 0.81
Absol diff 0.05
Rel % diff 6%
ns
Katon RCT General adherence to exercise
score
Int: 0.54 Con: 0.44
Absol diff 0.1
Rel % diff 23%
ns
Lorig RCT Exercise: stretching and strength-
ening (mins/week)
Int: 53.1
Con: 40.4
Absol diff 12.7
Rel % diff 31%
ns
Lorig RCT Exercise: aerobic (mins/week) Int: 101.8
Con: 88
Absol diff 13.8
Rel %diff 157%
ns
Lorig RCT Communication with doctor
(score 1-5)
Int:3.34
Con: 3.2
Absol diff 0.14
Rel %diff 4%
ns
Sommers RCT Nutrition checklist score Int:2.0
Con:1.9
Absol diff 0.1
Rel %diff 5%
ns
* refers to whether original study reported statistically significant improvement in this outcome
Table 9. Provider behaviour
Study Study type Outcome Result Notes
Boult RCT PACIC score (patient measure of
quality of care received)
Int: 3.14 Con: 2.85
Absol diff 0.29
Rel % diff 10%
*
Hogg RCT Chronic Disease Mangement Score Int: 0.84 Con: 0.77
Absol diff 0.07
Rel % diff 9%
*
Hogg RCT Preventive Care Score Int: 0.89 Con: 0.7
Absol diff 0.19
Rel % diff 27%
*
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Table 9. Provider behaviour (Continued)
Krska RCT % Pharmaceutical care issues re-
solved from baseline
Int: 950/1206
Con: 542/1380
Absol diff 0.4
Rel% diff 102%
*
* refers to whether original study reported statistically significant improvement in this outcome
Table 10. Costs
Study Study type Outcome Result Notes
Boult RCT Total healthcare cost Saving of $75,000 per GCN and
$1364 per patient
$ in 2007
Initial result only
ns
Katon RCT Mean cost per patient $1224 per patient $ over 12 month intervention pe-
riod in late 2000s
Krska RCT Mean cost of medicines Int: 38.83
Con: 42.61
Absol diff 3.78
Rel %diff 9%
£ in 2000
ns
SES=0.13
Lorig RCT Intervention cost per completed
participant
$70 $ in 1998
See text for assumptions made
Lorig RCT Cost savings per patient $750 $ in 1998
See text for assumptions made
Sommers RCT Savings per patient $90 $ in 1994
See text for assumptions made
* refers to whether original study reported statistically significant improvement in this outcome
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A P P E N D I C E S
Appendix 1. MEDLINE search strategies 2007, 2009, 2011
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1948 to 2011>
--------------------------------------------------------------------------------
1 Comorbidity/ (48809)
2 (comorbid$ or co-morbid$).ti,ab. (52767)
3 (multimorbid$ or multi-morbid$).ti,ab. (712)
4 (multidisease? or multi-disease? or (multiple adj (ill$ or disease? or condition? or syndrom$ or disorder?))).ti,ab. (1619)
5 or/1-4 (88625)
6 Chronic disease/ (196972)
7 (chronic$ adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or medication$ or syndrom$ or symptom$)).ti,ab.
(172333)
8 or/6-7 (329439)
9 5 or 8 (408710)
10 exp diabetes mellitus/ or diabet$.ti,ab. (368459)
11 exp hypertension/ or (hypertens$ or “high blood pressure?”).ti,ab. (316662)
12 exp heart diseases/ or (((heart or cardiac or cardiovascular or coronary) adj (disease? or disorder? or failure)) or arrythmia?).ti,ab.
(882594)
13 exp cerebrovascular disorders/ or ((cerebrovascular or vascular or carotoid$ or arter$) adj (disorder? or disease?)).ti,ab. (315505)
14 exp asthma/ or asthma$.ti,ab. (118910)
15 exp pulmonary disease chronic obstructive/ or (copd or (pulmonary adj2 (disease? or disorder?))).ti,ab. (45836)
16 exp hyperlipidemia/ or (hyperlipidem$ or Hypercholesterolemia$ or hypertriglyceridemia$).ti,ab. (65312)
17 exp Thyroid diseases/ or ((thyroid adj (disease? or disorder)) or hyperthyroid$ or hypothyroid$).ti,ab. (115901)
18 exp arthritis rheumatoid/ or rheumatoid arthritis.ti,ab. (103792)
19 exp mental disorders/ or (((mental or anxiety or mood or psychological or sleep) adj (disease? or disorder?)) or ((substance or drug
or marijuana or cocaine or Amphetamine) adj2 abuse) or depression or schizophren$ or psychos$ or “substance abuse” or addiction?
).ti,ab. (971649)
20 exp epilepsy/ or (epileps$ or seizure?).ti,ab. (142567)
21 exp hiv infections/ or (HIV or acquired immune$ deficiency syndrome? or (aids adj (associated or related or arteritis))).ti,ab.
(255123)
22 exp neoplasms/ or (neoplasm? or cancer?).ti,ab. (2345120)
23 exp kidney diseases/ or (kidney adj (disease? or disorder?)).ti,ab. (363164)
24 exp liver diseases/ or (liver adj (disease? or disorder?)).ti,ab. (387359)
25 exp osteoporosis/ or osteoporosis.ti,ab. (50531)
26 or/10-25 (5831119)
27 ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or
medication$ or symptom$ or syndrom$)).ti,ab. (35702)
28 chronic$.ti,ab,hw. (816669)
29 27 or 28 (847460)
30 26 and 29 (490847)
31 exp *education, continuing/ (27307)
32 (education$ adj2 (program$ or intervention? or meeting? or session? or strateg$ or workshop? or visit?)).tw. (34430)
33 (behavio?r$ adj2 intervention?).tw. (5300)
34 *pamphlets/ (1206)
35 (leaflet? or booklet? or poster or posters).tw. (17194)
36 ((written or printed or oral) adj information).tw. (1190)
37 (information$ adj2 campaign).tw. (314)
38 (education$ adj1 (method? or material?)).tw. (3637)
39 *advance directives/ (2523)
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40 outreach.tw. (5976)
41 ((opinion or education$ or influential) adj1 leader?).tw. (705)
42 facilitator?.tw. (9507)
43 academic detailing.tw. (256)
44 consensus conference?.tw. (3391)
45 *guideline adherence/ (6574)
46 practice guideline?.tw. (10290)
47 (guideline? adj2 (introduc$ or issu$ or impact or effect? or disseminat$ or distribut$)).tw. (2446)
48 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 training program$).tw. (440)
49 *reminder systems/ (915)
50 reminder?.tw. (5184)
51 (recall adj2 system$).tw. (324)
52 (prompter? or prompting).tw. (3472)
53 algorithm?.tw. (93991)
54 *feedback/ or feedback.tw. (64356)
55 chart review$.tw. (16348)
56 ((effect? or impact or records or chart?) adj2 audit).tw. (630)
57 compliance.tw. (64556)
58 marketing.tw. (13755)
59 or/31-58 (373569)
60 exp *reimbursement mechanisms/ (14807)
61 fee for service.tw. (2797)
62 *capitation fee/ (1957)
63 *“deductibles and coinsurance”/ (514)
64 cost shar$.tw. (924)
65 (copayment? or co payment?).tw. (973)
66 (prepay$ or prepaid or prospective payment?).tw. (3894)
67 *hospital charges/ (750)
68 formular?.tw. (2408)
69 fundhold?.tw. (1)
70 *medicaid/ (8711)
71 *medicare/ (15463)
72 blue cross.tw. (992)
73 or/60-72 (44643)
74 *nurse clinicians/ (5175)
75 *nurse midwives/ (4229)
76 *nurse practitioners/ (9690)
77 (nurse adj (rehabilitator? or clinician? or practitioner? or midwi$)).tw. (8545)
78 *pharmacists/ (5519)
79 clinical pharmacist?.tw. (974)
80 paramedic?.tw. (2649)
81 *patient care team/ (17606)
82 exp *patient care planning/ (20139)
83 (team? adj2 (care or treatment or assessment or consultation)).tw. (7516)
84 (integrat$ adj2 (care or service?)).tw. (5080)
85 (care adj2 (coordinat$ or program$ or continuity)).tw. (14512)
86 (case adj1 management).tw. (6240)
87 exp *ambulatory care facilities/ (21896)
88 *ambulatory care/ (13520)
89 or/74-88 (125028)
90 *home care services/ (17652)
91 *hospices/ (2988)
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92 *nursing homes/ (17447)
93 *office visits/ (1775)
94 *house calls/ (1130)
95 *day care/ (2710)
96 *aftercare/ (2459)
97 *community health nursing/ (13879)
98 (chang$ adj1 location?).tw. (270)
99 domiciliary.tw. (2007)
100 (home adj1 treat$).tw. (1189)
101 day surgery.tw. (1709)
102 *medical records/ (14865)
103 *medical records systems, computerized/ (11752)
104 (information adj2 (management or system?)).tw. (20386)
105 *peer review/ (2810)
106 *utilization review/ (2436)
107 exp *health services misuse/ (2615)
108 or/90-107 (112686)
109 *physician’s practice patterns/ (18585)
110 quality assurance.tw. (15565)
111 *process assessment/ [health care] (1134)
112 *program evaluation/ (5726)
113 *length of stay/ (5765)
114 (early adj1 discharg$).tw. (1797)
115 discharge planning.tw. (1848)
116 offset.tw. (14530)
117 triage.tw. (6909)
118 exp *“Referral and Consultation”/ and “consultation”/ (16242)
119 *drug therapy, computer assisted/ (878)
120 near patient testing.tw. (167)
121 *medical history taking/ (3920)
122 *telephone/ (3648)
123 (physician patient adj (interaction? or relationship?)).tw. (1671)
124 *health maintenance organizations/ (9206)
125 managed care.tw. (15056)
126 (hospital? adj1 merg$).tw. (337)
127 or/109-126 (118024)
128 ((standard or usual or routine or regular or traditional or conventional or pattern) adj2 care).tw. (25123)
129 (program$ adj2 (reduc$ or increas$ or decreas$ or chang$ or improv$ or modify$ or monitor$ or care)).tw. (30065)
130 (program$ adj1 (health or care or intervention?)).tw. (23187)
131 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 treatment program$).tw. (257)
132 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 care program$).tw. (115)
133 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 screening program$).tw. (406)
134 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 prevent$ program$).tw. (340)
135 (computer$ adj2 (dosage or dosing or diagnosis or therapy or decision?)).tw. (3150)
136 ((introduc$ or impact or effect? or implement$ or computer$) adj2 protocol?).tw. (1953)
137 ((effect or impact or introduc$) adj2 (legislation or regulations or policy)).tw. (1177)
138 or/128-137 (76105)
139 or/59,73,89,108,127,138 (763155)
140 randomized controlled trial.pt. (303682)
141 controlled clinical trial.pt. (82106)
142 random$.ti,ab. (541169)
143 (control$ adj2 (trial? or study or studies)).ti,ab. (205818)
144 double-blind method/ or random allocation/ or single-blind method/ (184152)
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145 ((double or single or triple or treble) adj2 blind$).ti,ab. (107156)
146 (quasi-experiment$ or quasiexperiment$).ti,ab. (3965)
147 interrupt$ time series.ti,ab. (571)
148 or/140-147 (839267)
Search Results MEDLINE 2011
149 9 and 139 and 148 (4834)
150 30 and 139 and 148 (3564)
151 149 or 150 [FINAL RESULTS] (6142)
152 limit 151 to yr=“2009 -Current” (1334)
153 (2009* or 2010* or 2011*).ed,ep,dp. [Date Limits] (2360220)
154 (or/149-150) and 153 (1510)
155 152 or 154 (1510) [Results 2009 to 2011]
Search Results MEDLINE 2009
149 9 and 139 and 148 (1664)
150 9 and 139 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (2852)
151 30 and 139 and 148 (1125)
152 30 and 139 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (1822)
153 149 or 151 (2043) [Results before year limits]
154 limit 153 to (humans and yr=“2008 - 2009”) (468)
155 150 or 152 (3409)
156 limit 155 to (humans and yr=“2008 - 2009”) (787)
157 remove duplicates from 156 (467) [Set 1: 2008-2009]
158 156 or 152 (3409)
159 limit 158 to (humans and yr=“2008 - 2009”) (787)
160 159 not 157 (564) [Set 2: 2008-2009]
Database: Ovid MEDLINE(R) <1950 to January Week 3 2007>
1 (chronic adj (disease? or illness$ or care)).tw. (20969)
2 Comorbidity/ (27090)
3 (comorbid$ or co-morbid$).tw. (25216)
4 (multimorbid$ or multi-morbid$).tw. (412)
5 exp diabetes mellitus/ (203288)
6 exp hypertension/ (160279)
7 exp heart diseases/ (637458)
8 exp cerebrovascular disorders/ (186988)
9 exp asthma/ (78092)
10 exp pulmonary disease chronic obstructive/ or (chronic adj2 obstructive adj2 pulmonary).tw. (26538)
11 exp thyroid diseases/ (93440)
12 exp hyperlipidemia/ (43072)
13 exp arthritis rheumatoid/ (81863)
14 exp mental disorders/ (637448)
15 exp substance-related disorders/ or exp substance abuse/ (159869)
16 exp epilepsy/ (93966)
17 exp hiv infections/ (158869)
18 exp neoplasms/ (1778994)
19 exp kidney diseases/ (305680)
20 exp liver diseases/ (308939)
21 exp osteoporosis/ (29011)
22 or/1-21 (4309303)
23 exp Primary Health Care/ (45790)
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24 Physicians, Family/ (10609)
25 Family Practice/ (49656)
26 exp Community Health Services/ (346548)
27 (primary adj2 care).tw. (43606)
28 ((general or family) adj pract$).tw. (46963)
29 or/23-28 (457523)
30 22 and 29 (141530)
31 exp *education, continuing/ (23228)
32 (education$ adj2 (program$ or intervention? or meeting? or session? or strateg$ or workshop? or visit?)).tw. (22659)
33 (behavio?r$ adj2 intervention?).tw. (2940)
34 *pamphlets/ (1013)
35 (leaflet? or booklet? or poster or posters).tw. (11881)
36 ((written or printed or oral) adj information).tw. (808)
37 (information$ adj2 campaign).tw. (202)
38 (education$ adj1 (method? or material?)).tw. (2536)
39 *advance directives/ (2061)
40 outreach.tw. (3639)
41 ((opinion or education$ or influential) adj1 leader?).tw. (376)
42 facilitator?.tw. (6416)
43 academic detailing.tw. (150)
44 consensus conference?.tw. (2451)
45 *guideline adherence/ (3729)
46 practice guideline?.tw. (6014)
47 (guideline? adj2 (introduc$ or issu$ or impact or effect? or disseminat$ or distribut$)).tw. (1598)
48 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 training program$).tw. (278)
49 *reminder systems/ (557)
50 reminder?.tw. (3314)
51 (recall adj2 system$).tw. (243)
52 (prompter? or prompting).tw. (2127)
53 algorithm?.tw. (46160)
54 *feedback/ or feedback.tw. (41492)
55 chart review$.tw. (9673)
56 ((effect? or impact or records or chart?) adj2 audit).tw. (448)
57 compliance.tw. (47206)
58 marketing.tw. (9523)
59 or/31-58 (238366)
60 exp *reimbursement mechanisms/ (12118)
61 fee for service.tw. (2172)
62 *capitation fee/ (1883)
63 *“deductibles and coinsurance”/ (411)
64 cost shar$.tw. (584)
65 (copayment? or co payment?).tw. (573)
66 (prepay$ or prepaid or prospective payment?).tw. (3505)
67 *hospital charges/ (598)
68 formular?.tw. (1823)
69 fundhold?.tw. (1)
70 *medicaid/ (7518)
71 *medicare/ (13478)
72 blue cross.tw. (882)
73 or/60-72 (37422)
74 *nurse clinicians/ (4463)
75 *nurse midwives/ (3985)
76 *nurse practitioners/ (8022)
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77 (nurse adj (rehabilitator? or clinician? or practitioner? or midwi$)).tw. (6622)
78 *pharmacists/ (4022)
79 clinical pharmacist?.tw. (655)
80 paramedic?.tw. (1918)
81 *patient care team/ (14109)
82 exp *patient care planning/ (16742)
83 (team? adj2 (care or treatment or assessment or consultation)).tw. (5202)
84 (integrat$ adj2 (care or service?)).tw. (3085)
85 (care adj2 (coordinat$ or program$ or continuity)).tw. (10081)
86 (case adj1 management).tw. (4686)
87 exp *ambulatory care facilities/ (18216)
88 *ambulatory care/ (11098)
89 or/74-88 (98447)
90 *home care services/ (15097)
91 *hospices/ (2657)
92 *nursing homes/ (14890)
93 *office visits/ (1345)
94 *house calls/ (866)
95 *day care/ (2479)
96 *aftercare/ (2135)
97 *community health nursing/ (12518)
98 (chang$ adj1 location?).tw. (166)
99 domiciliary.tw. (1684)
100 (home adj1 treat$).tw. (914)
101 day surgery.tw. (1309)
102 *medical records/ (13462)
103 *medical records systems, computerized/ (7928)
104 (information adj2 (management or system?)).tw. (13965)
105 *peer review/ (2508)
106 *utilization review/ (2302)
107 exp *health services misuse/ (2058)
108 or/90-107 (92011)
109 *physician’s practice patterns/ (12061)
110 quality assurance.tw. (12097)
111 *process assessment/ [health care] (829)
112 *program evaluation/ (3705)
113 *length of stay/ (4521)
114 (early adj1 discharg$).tw. (1385)
115 discharge planning.tw. (1487)
116 offset.tw. (9503)
117 triage.tw. (4147)
118 exp *“Referral and Consultation”/ and “consultation”/ (13190)
119 *drug therapy, computer assisted/ (616)
120 near patient testing.tw. (135)
121 *medical history taking/ (3244)
122 *telephone/ (3062)
123 (physician patient adj (interaction? or relationship?)).tw. (1211)
124 *health maintenance organizations/ (8981)
125 managed care.tw. (13505)
126 (hospital? adj1 merg$).tw. (308)
127 or/109-126 (89787)
128 ((standard or usual or routine or regular or traditional or conventional or pattern) adj2 care).tw. (13514)
129 (program$ adj2 (reduc$ or increas$ or decreas$ or chang$ or improv$ or modify$ or monitor$ or care)).tw. (19670)
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130 (program$ adj1 (health or care or intervention?)).tw. (15915)
131 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 treatment program$).tw. (202)
132 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 care program$).tw. (89)
133 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 screening program$).tw. (310)
134 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 prevent$ program$).tw. (224)
135 (computer$ adj2 (dosage or dosing or diagnosis or therapy or decision?)).tw. (2210)
136 ((introduc$ or impact or effect? or implement$ or computer$) adj2 protocol?).tw. (1074)
137 ((effect or impact or introduc$) adj2 (legislation or regulations or policy)).tw. (707)
138 or/128-137 (47148)
139 59 or 73 or 89 or 108 or 127 or 138 (539518)
140 randomized controlled trial.pt. (227480)
141 controlled clinical trial.pt. (73834)
142 intervention studies/ (3363)
143 experiment$.tw. (823731)
144 (time adj series).tw. (6024)
145 (pre test or pretest or posttest or post test).tw. (7407)
146 random allocation/ (56614)
147 intervention?.tw. (231845)
148 evaluation studies/ (116150)
149 comparative study.pt. (1305975)
150 or/140-149 (2480883)
151 animal/ (3964641)
152 human/ (9515859)
153 151 not (151 and 152) (3014465)
154 150 not 153 (1767123)
155 30 and 139 and 154 (10979)
156 limit 155 to review (1156)
157 155 not 156 (9823)
158 meta-analysis.pt. (14191)
159 157 not 158 (9776) [2007 MEDLINE Search Results]
Appendix 2. EMBASE Search Strategy 2009, 2011
Database: EMBASE Classic+EMBASE <1947 to 2011 April 07>
1 Comorbidity/ (82841)
2 (comorbid$ or co-morbid$).ti,ab. (69356)
3 (multimorbid$ or multi-morbid$).ti,ab. (1069)
4 (multidisease? or multi-disease? or (multiple adj (ill$ or disease? or condition? or syndrom$ or disorder?))).ti,ab. (2003)
5 or/1-4 (114644)
6 Chronic disease/ (136264)
7 (chronic$ adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or medication$ or syndrom$ or symptom$)).ti,ab.
(226486)
8 or/6-7 (324583)
9 5 or 8 (428959)
10 exp diabetes mellitus/ or diabet$.ti,ab. (541521)
11 exp hypertension/ or (hypertens$ or “high blood pressure?”).ti,ab. (521511)
12 exp heart disease/ or exp myocardial disease/ or (((heart or cardiac or cardiovascular or coronary) adj (disease? or disorder? or failure))
or arrythmia?).ti,ab. (1267000)
13 cerebrovascular disease/ or carotid artery disease/ or ((cerebrovascular or vascular or carotoid$ or arter$) adj (disorder? or disease?
)).ti,ab. (170311)
14 exp asthma/ or asthma$.ti,ab. (182043)
15 Chronic Obstructive Lung Disease/ or (copd or ((pulmonary or lung?) adj2 (disease? or disorder?))).ti,ab. (112836)
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16 exp hyperlipidemia/ or exp hypercholesterolemia/ or (hyperlipidem$ or Hypercholesterolemia$ or hypertriglyceridemia$).ti,ab.
(103018)
17 exp Thyroid disease/ or ((thyroid adj (disease? or disorder)) or hyperthyroid$ or hypothyroid$).ti,ab. (176510)
18 exp rheumatoid arthritis/ or rheumatoid arthritis.ti,ab. (142292)
19 exp mental disease/ or (((mental or anxiety or mood or psychological or sleep) adj (disease? or disorder?)) or ((substance or drug
or marijuana or cocaine or Amphetamine) adj2 abuse) or depression or schizophren$ or psychos$ or “substance abuse” or addiction?
).ti,ab. (1557080)
20 exp epilepsy/ or (epileps$ or seizure?).ti,ab. (203785)
21Human Immunodeficiency Virus/ or (HIV or acquired immune$ deficiency syndrome? or (aids adj (associated or related or arteritis))
or human immunodeficiency).ti,ab. (240745)
22 exp neoplasm/ or (neoplasm? or cancer?).ti,ab. (3120478)
23 exp kidney disease/ or ((kidney? or renal) adj (disease? or disorder? or failure)).ti,ab. (610122)
24 exp liver disease/ or (liver adj (disease? or disorder?)).ti,ab. (598717)
25 exp osteoporosis/ or osteoporosis.ti,ab. (83134)
26 or/10-25 (7896479) [CHRONIC DISEASES]
27 ((coocur$ or co-ocur$ or coexist$ or co-exist$ or multipl$) adj3 (disease? or ill$ or care or condition? or disorder$ or health$ or
medication$ or symptom$ or syndrom$)).ti,ab. (49330)
28 chronic$.ti,ab,hw. (1069293)
29 27 or 28 (1112010) [COMORBIDITY KW]
30 26 and 29 (679455)
31 exp primary health care/ or exp primary medical care/ (81649)
32 (primary adj2 (care? or medical$ or health$ or clinic$ or practitioner? or doctor?)).ti,ab. (85021)
33 General practitioner/ (49989)
34 (((family or general or generalist? or communit$) adj2 (physician? or doctor? or practitioner? or practice)) or GP).ti,ab. (121960)
35 General Practice/ (64045)
36 exp Community Care/ (85297)
37 (communit$ adj2 (health or healthcare or service? or clinic$ or setting? or centre? or center?)).ti,ab. (42367)
38 or/31-37 (362774) [PRIMARY/COMMUNITY CARE]
39 (education$ adj2 (program$ or intervention? or meeting? or session? or strateg$ or workshop? or visit?)).tw. (41473)
40 (behavio?r$ adj2 intervention?).tw. (6575)
41 (leaflet? or booklet? or poster or posters).tw. (21974)
42 ((written or printed or oral) adj information).tw. (1610)
43 (information$ adj2 campaign).tw. (376)
44 (education$ adj1 (method? or material?)).tw. (4967)
45 outreach.tw. (6722)
46 ((opinion or education$ or influential) adj1 leader?).tw. (810)
47 facilitator?.tw. (11340)
48 academic detailing.tw. (325)
49 consensus conference?.tw. (4389)
50 practice guideline?.tw. (12316)
51 (guideline? adj2 (introduc$ or issu$ or impact or effect? or disseminat$ or distribut$)).tw. (3162)
52 ((introduc$ or impact or effect? or implement$ or computer$ or compli$) adj2 protocol?).tw. (2901)
53 ((introduc$ or impact or effect? or implement$ or computer$ or compli$) adj2 algorithm?).tw. (4415)
54 clinical pathway?.tw. (1837)
55 critical pathway?.tw. (1063)
56 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 training program$).tw. (541)
57 reminder?.tw. (6421)
58 (recall adj2 system$).tw. (379)
59 (prompter? or prompting).tw. (4238)
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60 advance directive?.tw. (2383)
61 *feedback/ or feedback.tw. (77098)
62 chart review$.tw. (20152)
63 ((effect? or impact or records or chart?) adj2 audit).tw. (732)
64 compliance.tw. (85055)
65 marketing.tw. (17272)
66 ((cost or clinical or medical) adj information).tw. (16932)
67 *medical education/ (88351)
68 *medical audit/ (7236)
69 continuing education/ (24259)
70 postgraduate education/ (10841)
71 or/39-70 (454670)
72 fee for service.tw. (3250)
73 cost shar$.tw. (1072)
74 (copayment? or co payment?).tw. (1190)
75 (prepay$ or prepaid or prospective payment?).tw. (4606)
76 formular?.tw. (3596)
77 fundhold?.tw. (1)
78 blue cross.tw. (1270)
79 voucher?.tw. (784)
80 (free adj2 care).tw. (989)
81 exp *health insurance/ (76709)
82 *health care costs/ (22888)
83 *health care financing/ (2898)
84 *medical fee/ (3754)
85 *prospective payment/ (3600)
86 or/72-85 (111711)
87 (nurse adj (rehabilitator? or clinician? or practitioner? or midwi$)).tw. (9599)
88 ((nurse or midwi$ or practitioner) adj managed).tw. (483)
89 clinical pharmacist?.tw. (1511)
90 paramedic?.tw. (2967)
91 exp *paramedical personnel/ (150569)
92 *general practitioner/ (12680)
93 *physician/ (39648)
94 (team? adj2 (care or treatment or assessment or consultation)).tw. (9621)
95 (integrat$ adj2 (care or service?)).tw. (6230)
96 (care adj2 (coordinat$ or program$ or continuity)).tw. (17458)
97 (case adj1 management).tw. (7143)
98 *patient care/ (35434)
99 (chang$ adj1 location?).tw. (322)
100 domiciliary.tw. (2995)
101 (home adj1 (treat$ or visit?)).tw. (6036)
102 day surgery.tw. (2312)
103 exp *primary health care/ (32665)
104 *ambulatory surgery/ (5447)
105 *nursing home/ (20222)
106 *day hospital/ (1295)
107 *outpatient care/ (2584)
108 *terminal care/ (11841)
109 *group practice/ (5508)
110 *general practice/ (35609)
111 *rural health care/ (5461)
112 *community mental health center/ (1890)
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113 information system/ (28190)
114 *medical record/ (30370)
115 (information adj2 (management or system?)).tw. (24521)
116 *peer review/ (4866)
117 *professional standards review organization/ (1497)
118 exp *clinical practice/ (19402)
119 quality assurance.tw. (19729)
120 exp *health care delivery/ (390497)
121 *health care quality/ (50102)
122 *professional practice/ (16218)
123 (early adj1 discharg$).tw. (2299)
124 discharge planning.tw. (2049)
125 offset.tw. (16637)
126 triage.tw. (8148)
127 near patient testing.tw. (209)
128 *patient referral/ (10832)
129 (physician patient adj (interaction? or relationship?)).tw. (1870)
130 managed care.tw. (17248)
131 *health care organization/ (37240)
132 *health maintenance organization/ (8550)
133 *health care system/ (10198)
134 *health care access/ (4001)
135 (hospital? adj1 merg$).tw. (374)
136 (computer$ adj2 (dosage or dosing or diagnosis therapy or decision?)).tw. (1218)
137 (computer$ adj2 (diagnosis or therapy)).tw. (2589)
138 gatekeep$.tw. (2510)
139 or/87-138 (948412)
140 ((standard or usual or routine or regular or traditional or conventional or pattern) adj2 care).tw. (31677)
141 (program$ adj2 (reduc$ or increas$ or decreas$ or chang$ or improv$ or modify$ or monitor$ or care)).tw. (36983)
142 (program$ adj1 (health or care or intervention?)).tw. (27734)
143 ((effect or impact or introduc$) adj2 (legislation or regulations or policy)).tw. (1452)
144 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 treatment program$).tw. (349)
145 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 care program$).tw. (134)
146 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 screening program$).tw. (495)
147 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 prevent$ program$).tw. (388)
148 or/140-147 (87770)
149 71 or 86 or 139 or 148 (1459644)
150 randomized controlled trial/ or controlled clinical trial/ or clinical trial/ or controlled study/ (3959072)
151 random$.ti,ab. (658367)
152 (control$ adj2 (trial? or study or studies)).ti,ab. (253170)
153 ((double or single or triple or treble) adj2 blind$).ti,ab. (138000)
154 (quasi-experiment$ or quasiexperiment$).ti,ab. (4424)
155 interrupt$ time series.ti,ab. (655)
156 or/150-155 (4289901)
EMBASE 2009 Search Results
157 9 and 38 and 149 and 156 (1647)
158 9 and 38 and 149 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (1104)
159 30 and 38 and 149 and 156 (1209)
160 30 and 38 and 149 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (817)
161 157 or 159 (2040)
162 limit 161 to human (2007)
163 158 or 160 (1340)
164 limit 163 to human (1265)
52Interventions for improving outcomes in patients with multimorbidity in primary care and community settings (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
EMBASE 2011 Search Results
157 9 and 38 and 149 and 156 (2770)
158 9 and 38 and 149 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (2477)
159 30 and 38 and 149 and 156 (1969)
160 30 and 38 and 149 and (intervent$.ti,ab,pt. or evaluat$.ti,hw. or impact$.ti.) (1710)
161 157 or 159 (3348)
162 (2009* or 2010* or 2011*).em. (2420210)
163 (2009* or 2010* or 2011*).dp. (401327)
164 161 and (or/162-163) (920)
Appendix 3. CAB Abstracts Strategy 2009, 2011
CAB Abstracts Search Strategy 2007 to 05-01-2009
S7 S2 and S6 Interface - EBSCOhost
Search Screen - Advanced Search
Database - CAB Abstracts; Expanders - Apply related words
Search modes - Boolean/Phrase
(87)
S6 AB ( “pretest* or ”pre-test* or posttest* or “post-test*” or
quasiexperiment* or “quasi-experiment*” or control* or ran-
dom* or “time series” or before or intervention* or multicen-
ter or multicentre or policy or policies or protocol or guide-
line* or trial* or “evidence base*” or pilot* or quasirandom*
or “quasi-random*” or quasicontrol* or “quasi-control*” or
cost* or implement* or “single blind*” or “double blind*” or
“triple blind*” or blinded or blinding or economic* or out-
come* ) or TI ( “pretest* or ”pre-test* or posttest* or “post-
test*” or quasiexperiment* or “quasi-experiment*” or con-
trol* or random* or “time series” or before or intervention*
or multicenter or multicentre or policy or policies or protocol
or guideline* or trial* or “evidence base*” or pilot* or quasir-
andom* or “quasi-random*” or quasicontrol* or “quasi-con-
trol*” or cost* or implement* or “single blind*” or “dou-
ble blind*” or “triple blind*” or blinded or blinding or or
economic* or outcome* ) or SU ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* ) or DU ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
Limiters - Publication Year from: 2007-2009; Broad Cate-
gory: Human Sciences
Search modes - SmartText Searching
(27147)
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(Continued)
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* )AB ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* )AB ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* ) or TI ( “pre ...Show Less
S5 AB ( ”pretest* or “pre-test* or posttest* or ”post-test*“ or
quasiexperiment* or ”quasi-experiment*“ or control* or ran-
dom* or ”time series“ or before or intervention* or multicen-
ter or multicentre or policy or policies or protocol or guide-
line* or trial* or ”evidence base*“ or pilot* or quasirandom*
or ”quasi-random*“ or quasicontrol* or ”quasi-control*“ or
cost* or implement* or ”single blind*“ or ”double blind*“ or
”triple blind*“ or blinded or blinding or economic* or out-
come* ) or TI ( ”pretest* or “pre-test* or posttest* or ”post-
test*“ or quasiexperiment* or ”quasi-experiment*“ or con-
trol* or random* or ”time series“ or before or intervention*
or multicenter or multicentre or policy or policies or protocol
or guideline* or trial* or ”evidence base*“ or pilot* or quasir-
andom* or ”quasi-random*“ or quasicontrol* or ”quasi-con-
trol*“ or cost* or implement* or ”single blind*“ or ”dou-
ble blind*“ or ”triple blind*“ or blinded or blinding or or
economic* or outcome* ) or SU ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* ) or DU ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
Limiters - Publication Year from: 2007-2009; Broad Cate-
gory: Human Sciences
Search modes - Boolean/Phrase [number of results for this
line did not display when screen shot was taken to record this
strategy]
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iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* )AB ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* )AB ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* ) or TI ( ”pre ...Show Less
S4 AB ( “pretest* or ”pre-test* or posttest* or “post-test*” or
quasiexperiment* or “quasi-experiment*” or control* or ran-
dom* or “time series” or before or intervention* or multicen-
ter or multicentre or policy or policies or protocol or guide-
line* or trial* or “evidence base*” or pilot* or quasirandom*
or “quasi-random*” or quasicontrol* or “quasi-control*” or
cost* or implement* or “single blind*” or “double blind*” or
“triple blind*” or blinded or blinding or economic* or out-
come* ) or TI ( “pretest* or ”pre-test* or posttest* or “post-
test*” or quasiexperiment* or “quasi-experiment*” or con-
trol* or random* or “time series” or before or intervention*
or multicenter or multicentre or policy or policies or protocol
or guideline* or trial* or “evidence base*” or pilot* or quasir-
andom* or “quasi-random*” or quasicontrol* or “quasi-con-
trol*” or cost* or implement* or “single blind*” or “dou-
ble blind*” or “triple blind*” or blinded or blinding or or
economic* or outcome* ) or SU ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* ) or DU ( “pretest* or ”pre-test* or
Expanders - Apply related words
Search modes - SmartText Searching
(427444)
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posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* )AB ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* )AB ( “pretest* or ”pre-test* or
posttest* or “post-test*” or quasiexperiment* or “quasi-exper-
iment*” or control* or random* or “time series” or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or “evidence base*” or
pilot* or quasirandom* or “quasi-random*” or quasicontrol*
or “quasi-control*” or cost* or implement* or “single blind*”
or “double blind*” or “triple blind*” or blinded or blinding
or economic* or outcome* ) or TI ( “pre ...Show Less
S3 AB ( ”pretest* or “pre-test* or posttest* or ”post-test*“ or
quasiexperiment* or ”quasi-experiment*“ or control* or ran-
dom* or ”time series“ or before or intervention* or multicen-
ter or multicentre or policy or policies or protocol or guide-
line* or trial* or ”evidence base*“ or pilot* or quasirandom*
or ”quasi-random*“ or quasicontrol* or ”quasi-control*“ or
cost* or implement* or ”single blind*“ or ”double blind*“ or
”triple blind*“ or blinded or blinding or economic* or out-
come* ) or TI ( ”pretest* or “pre-test* or posttest* or ”post-
test*“ or quasiexperiment* or ”quasi-experiment*“ or con-
trol* or random* or ”time series“ or before or intervention*
or multicenter or multicentre or policy or policies or protocol
or guideline* or trial* or ”evidence base*“ or pilot* or quasir-
andom* or ”quasi-random*“ or quasicontrol* or ”quasi-con-
trol*“ or cost* or implement* or ”single blind*“ or ”dou-
ble blind*“ or ”triple blind*“ or blinded or blinding or or
economic* or outcome* ) or SU ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
Expanders - Apply related words
Search modes - Boolean/Phrase
[number of results for this line did not display when screen
shot was taken to record this strategy]
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or economic* or outcome* ) or DU ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* )AB ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* )AB ( ”pretest* or “pre-test* or
posttest* or ”post-test*“ or quasiexperiment* or ”quasi-exper-
iment*“ or control* or random* or ”time series“ or before or
intervention* or multicenter or multicentre or policy or poli-
cies or protocol or guideline* or trial* or ”evidence base*“ or
pilot* or quasirandom* or ”quasi-random*“ or quasicontrol*
or ”quasi-control*“ or cost* or implement* or ”single blind*“
or ”double blind*“ or ”triple blind*“ or blinded or blinding
or economic* or outcome* ) or TI ( ”pre ...Show Less
S2 AB ( “co-morbid*” or multimorbid* ) or TI ( “co-morbid*”
or multimorbid* ) or SU ( “co-morbid*” or multimorbid* )
Limiters - Publication Year from: 2007-2009; Broad Cate-
gory: Human Sciences
Expanders - Apply related words
Search modes - Boolean/Phrase
(315)
S1 AB ( “co-morbid*” or multimorbid* ) or TI ( “co-morbid*”
or multimorbid* ) or SU ( “co-morbid*” or multimorbid* )
Expanders - Apply related words
Search modes - Boolean/Phrase
(804)
Appendix 4. Cochrane Central Register of Controlled Trials Strategy 2009, 2011
Search Name: Multimorbidity 1.2
Comments: 25/05/2011
Save Date: 2011-05-25 12:43:54.87
IDSearch
#1MeSH descriptor Comorbidity, this term only
#2(comorbid* or co-morbid* or multimorbid* or multi-morbid* or multidisease or multidiseases or multi-disease or multi-diseases):ti
#3MeSH descriptor Chronic Disease, this term only
#4(#1 OR #2 OR ( #2 AND #3 ))
#5MeSH descriptor Diabetes Mellitus explode tree 2
#6diabet*:ti,ab
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#7MeSH descriptor Hypertension explode all trees
#8(hypertens* or “high blood pressure”):ti,ab
#9MeSH descriptor Heart Diseases explode all trees
#10MeSH descriptor Cerebrovascular Disorders explode tree 1
#11(cerebrovascular disorder* or cerebrovascular disease* or vascular disorder* or vascular disease* or carotoid* disorder* or carotoid
disease* or arter* disorder* or arter* disease*):ti
#12MeSH descriptor Asthma explode tree 2
#13asthma*:ti
#14MeSH descriptor Pulmonary Disease, Chronic Obstructive explode all trees
#15(copd or pulmonary disease* or pulmonary disorder*):ti
#16MeSH descriptor Hyperlipidemias explode all trees
#17(hyperlipidem* or Hypercholesterolemia* or hypertriglyceridemia*):ti
#18MeSH descriptor Thyroid Diseases explode all trees
#19(thyroid disease* or thyroid disorder*):ti
#20MeSH descriptor Mental Disorders explode all trees
#21((mental or anxiety or mood or psychological or sleep) NEAR/2 (disease* or disorder*)):ti
#22((substance or drug or marijuana or cocaine or Amphetamine) NEAR/2 abuse):ti
#23(depression or schizophren* or psychos* or “substance abuse” or addiction or addictions):ti
#24MeSH descriptor Epilepsy explode all trees
#25(epileps* or seizure or seizures):ti
#26MeSH descriptor HIV Infections explode tree 1
#27(HIV or acquired immune* deficiency syndrome*):ti
#28MeSH descriptor Neoplasms explode all trees
#29(neoplasm or cancer):ti
#30MeSH descriptor Kidney Diseases explode tree 1
#31(kidney disease* or kidney disorder*):ti
#32MeSH descriptor Liver Diseases explode all trees
#33(liver disease* or liver disorder*):ti
#34MeSH descriptor Osteoporosis explode all trees
#35osteoporosis:ti
#36(#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20
OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35)
#37((coocur* or co-ocur* or coexist* or co-exist* or multipl*) NEAR/2 (disease or diseases or ill* or care or condition or conditions or
disorder* or health* or medication* or symptom* or syndrom*)):ti,ab
#38(#36 AND #37)
#39(#4 OR #38)
Appendix 5. CINAHL Strategy
Limiters/Expanders Last Run Via Results
S70 S26 or S66 or S67 or S68 or S69 Date from: 20090101-20111231
Interface - EBSCOhost
Search Screen - Advanced Search
Database - CINAHL
1149
S69 S3 AND S51 AND S64 Expanders - Apply related words
Search modes - Boolean/Phrase
5313
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(Continued)
S68 (S24 or S25) AND S51 Expanders - Apply related words
Search modes - Boolean/Phrase
378
S67 (S24 or S25) AND S58 Expanders - Apply related words
Search modes - Boolean/Phrase
173
S66 S3 and S58 Expanders - Apply related words
Search modes - Boolean/Phrase
1781
S65 S59 or S60 or S61 or S62 or S63 Expanders - Apply related words
Search modes - Boolean/Phrase
927340
S64 S59 or S60 or S61 or S62 or S63 Expanders - Apply related words
Search modes - Boolean/Phrase
927340
S63 MW care or patient or community Expanders - Apply related words
Search modes - Boolean/Phrase
864406
S62 (MH “Community Health Services+”) Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S61 (MH “Primary Health Care”) Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S60 (MH “Physicians, Family”) or TI (fam-
ily physician? or family doctor?) or AB
(family doctor? or family physician?)
Expanders - Apply related words
Search modes - Boolean/Phrase
7946
S59 (MH “Family Practice”) or (family prac-
tice) or (general practice) or (family prac-
titioner*) or (general practitioner*) or
(family doctor*)
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S58 S52 or S53 or S54 or S55 or S56 or S57 Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S57 TI controlled Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S56 TI ( “control* N1 clinical” or “con-
trol* N1 group*” or “control* N1 trial*”
or “control* N1 study” or “control*
N1 studies” or “control* N1 design*”
or “control* N1 method*” ) or AB (
“control* N1 clinical” or “control* N1
group*” or “control* N1 trial*” or “con-
trol* N1 study” or “control* N1 studies”
or “control*N1design*” or “control*N1
method*” )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
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(Continued)
S55 TI random* or AB random* Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S54 TI ( “clinical study” or “clinical studies” )
or AB ( “clinical study” or “clinical stud-
ies” )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S53 (MM “Clinical Trials+”) Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S52 TI ( (multicent* n2 design*) or (multi-
cent* n2 study) or (multicent* n2 stud-
ies) or (multicent* n2 trial*) ) or AB (
(multicent* n2 design*) or (multicent*
n2 study) or (multicent* n2 studies) or
(multicent* n2 trial*) )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S51 S27 or S28 or S29 or S30 or S31 or S32
or S33 or S34 or S35 or S36 or S37 or
S38 or S39 or S40 or S41 or S42 or S43
or S44 or S45 or S46 or S47 or S48 or
S49 or S50
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S50 TI ( (time points n3 over) or (time points
n3 multiple) or (time points n3 three)
or (time points n3 four) or (time points
n3 five) or (time points n3 six) or (time
points n3 seven) or (time points n3 eight)
or (time points n3 nine) or (time points
n3 ten) or (time points n3 eleven) or
(time points n3 twelve) or (time points
n3 month*) or (time points n3 hour*)
or (time points n3 day*) or (time points
n3 “more than”) ) or AB ( (time points
n3 over) or (time points n3 multiple) or
(time points n3 three) or (time points n3
four) or (time points n3 five) or (time
points n3 six) or (time points n3 seven)
or (time points n3 eight) or (time points
n3 nine) or (time points n3 ten) or (time
points n3 eleven) or (time points n3
twelve) or (time points n3 month*) or
(time points n3 hour*) or (time points
n3 day*) or (time points n3 “more than”)
)
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S49 TI ( (control w3 area) or (control w3
cohort*) or (control w3 compar*) or
(control w3 condition) or (control w3
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
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group*) or (control w3 intervention*) or
(control w3 participant*) or (control w3
study) ) orAB ( (control w3 area) or (con-
trol w3 cohort*) or (control w3 compar*)
or (control w3 condition) or (control w3
group*) or (control w3 intervention*) or
(control w3 participant*) or (control w3
study) )
S48 TI ( multicentre or multicenter or multi-
centre or multi-center ) or AB random*
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S47 TI random* OR controlled Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S46 TI ( trial or (study n3 aim) or “our study”
) or AB ( (study n3 aim) or “our study” )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S45 TI ( pre-workshop or preworkshop or
post-workshop or postworkshop or (be-
fore n3 workshop) or (after n3 work-
shop) ) or AB ( pre-workshop or pre-
workshop or post-workshop or post-
workshop or (before n3 workshop) or
(after n3 workshop) )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S44 TI ( demonstration project OR demon-
stration projects OR preimplement* or
pre-implement* or post-implement* or
postimplement* ) or AB ( demonstra-
tion project OR demonstration projects
OR preimplement* or pre-implement*
or post-implement* or postimplement*
)
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S43 (intervention n6 clinician*) or (inter-
vention n6 community) or (interven-
tion n6 complex) or (intervention n6 de-
sign*) or (intervention n6 doctor*) or
(intervention n6 educational) or (inter-
vention n6 family doctor*) or (interven-
tion n6 family physician*) or (interven-
tion n6 family practitioner*) or (inter-
vention n6 financial) or (intervention n6
GP) or (intervention n6 general prac-
tice*) Or (intervention n6 hospital*) or
(intervention n6 impact*) Or (interven-
tion n6 improv*) or (intervention n6 in-
dividualize*) Or (intervention n6 indi-
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
61Interventions for improving outcomes in patients with multimorbidity in primary care and community settings (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
vidualise*) or (intervention n6 individu-
alizing) or (intervention n6 individualis-
ing) or (intervention n6 interdisciplin*)
or (intervention n6 multicomponent) or
(intervention n6 multi-component) or
(intervention n6 multidisciplin*) or (in-
tervention n6 multi-disciplin*) or (in-
tervention n6 multifacet*) or (interven-
tion n6 multi-facet*) or (intervention n6
multimodal*) or (intervention n6 multi-
modal*) or (intervention n6 personal-
ize*) or(intervention n6 personalise*) or
(intervention n6 personalizing) or (inter-
vention n6 personalising) or (interven-
tion n6 pharmaci*) or (intervention n6
pharmacist*) or (intervention n6 phar-
macy) or (intervention n6 physician*) or
(intervention n6 practitioner*) Or (in-
tervention n6 prescrib*) or (intervention
n6prescription*) or (interventionn6pri-
mary care) or (intervention n6 profes-
sional*) or (intervention* n6 provider*)
or (intervention* n6 regulatory) or (in-
tervention n6 regulatory) or (interven-
tion n6 tailor*) or (intervention n6 tar-
get*) or (intervention n6 team*) or (in-
tervention n6 usual care)
S42 TI ( collaborativ* or collaboration* or
tailored or personalised or personalized )
or AB ( collaborativ* or collaboration* or
tailored or personalised or personalized )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S41 TI pilot Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S40 (MH “Pilot Studies”) Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S39 AB “before-and-after” Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S38 AB time series Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S37 TI time series Expanders - Apply related words
Search modes - Boolean/Phrase
Display
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S36 AB ( before* n10 during or before n10
after ) or AU ( before* n10 during or
before n10 after )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S35 TI ( (time point*) or (period* n4 inter-
rupted) or (period* n4 multiple) or (pe-
riod* n4 time) or (period* n4 various)
or (period* n4 varying) or (period* n4
week*) or (period* n4 month*) or (pe-
riod* n4 year*) ) or AB ( (time point*)
or (period* n4 interrupted) or (period*
n4 multiple) or (period* n4 time) or (pe-
riod* n4 various) or (period* n4 vary-
ing) or (period* n4 week*) or (period*
n4 month*) or (period* n4 year*) )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S34 TI ( ( quasi-experiment* or quasiexper-
iment* or quasi-random* or quasiran-
dom* or quasi control* or quasicontrol*
or quasi* W3 method* or quasi* W3
study or quasi* W3 studies or quasi*
W3 trial or quasi* W3 design* or ex-
perimental W3 method* or experimen-
talW3 study or experimentalW3 studies
or experimental W3 trial or experimen-
tal W3 design* ) ) or AB ( ( quasi-experi-
ment* or quasiexperiment* or quasi-ran-
dom* or quasirandom* or quasi control*
or quasicontrol* or quasi* W3 method*
or quasi* W3 study or quasi* W3 studies
or quasi* W3 trial or quasi* W3 design*
or experimental W3 method* or exper-
imental W3 study or experimental W3
studies or experimental W3 trial or ex-
perimental W3 design* ) )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S33 TI pre w7 post or AB pre w7 post Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S32 MH “Multiple Time Series” or MH
“Time Series”
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S31 TI ( (comparative N2 study) or (compar-
ative N2 studies) or evaluation study or
evaluation studies ) or AB ( (comparative
N2 study) or (comparative N2 studies)
or evaluation study or evaluation studies
)
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
63Interventions for improving outcomes in patients with multimorbidity in primary care and community settings (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
S30 MH Experimental Studies or Commu-
nity Trials or Community Trials or
Pretest-Posttest Design + or Quasi-Ex-
perimental Studies + Pilot Studies or Pol-
icy Studies + Multicenter Studies
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S29 TI ( pre-test* or pretest* or posttest* or
post-test* ) orAB ( pre-test* or pretest* or
posttest* or “post test* ) OR TI ( preim-
plement*” or pre-implement* ) or AB (
pre-implement* or preimplement* )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S28 TI ( intervention* or multiintervention*
or multi-intervention* or postinterven-
tion* or post-intervention* or preinter-
vention* or pre-intervention* ) or AB
( intervention* or multiintervention*
or multi-intervention* or postinterven-
tion* or post-intervention* or preinter-
vention* or pre-intervention* )
Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S27 (MH “Quasi-Experimental Studies”) Expanders - Apply related words
Search modes - Boolean/Phrase
Display
S26 TI ( multimorbid* or multi-morbid* ) or
AB ( multimorbid* or multi-morbid* )
Expanders - Apply related words
Search modes - Boolean/Phrase
91
S25 s22 and s23 Expanders - Apply related words
Search modes - Boolean/Phrase
1504
S24 S6 and S23 Expanders - Apply related words
Search modes - Boolean/Phrase
163
S23 TI ( coocurr* or coexist* or co-ocurr* or
coexist* or co-exist*) or AB (coocurr* or
coexist* or co-ocurr* or coexist* or co-
exist*)
Expanders - Apply related words
Search modes - Boolean/Phrase
2525
S22 S7 or S8 or S9 or S10 or S11 or S12 or
S13 or S14 or S15 or S16 or S17 or S18
or S19 or S20 or 21
Expanders - Apply related words
Search modes - Boolean/Phrase
654174
S21 TI diabet* or asthma* or chronic or dis-
ease
Expanders - Apply related words
Search modes - Boolean/Phrase
122978
S20 MW ( disease OR diseases ) or MW syn-
drome? or MW chronic
Expanders - Apply related words
Search modes - Boolean/Phrase
257724
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(Continued)
S19 (MM “Kidney Diseases+”) Expanders - Apply related words
Search modes - Boolean/Phrase
15581
S18 (MM “Osteoporosis+”) Expanders - Apply related words
Search modes - Boolean/Phrase
5571
S17 (MM “Neoplasms+”) Expanders - Apply related words
Search modes - Boolean/Phrase
110248
S16 (MM “Liver Diseases+”) Expanders - Apply related words
Search modes - Boolean/Phrase
11645
S15 (MM “Human Immunodeficiency
Virus+”)
Expanders - Apply related words
Search modes - Boolean/Phrase
2007
S14 (MH “Mental Disorders, Chronic”) OR
(MM “Mental Disorders+”)
Expanders - Apply related words
Search modes - Boolean/Phrase
133504
S13 (MM “Epilepsy+”) Expanders - Apply related words
Search modes - Boolean/Phrase
3755
S12 (MM “Arthritis+”) Expanders - Apply related words
Search modes - Boolean/Phrase
15603
S11 (MM “Thyroid Diseases+”) Expanders - Apply related words
Search modes - Boolean/Phrase
3068
S10 (MM “Lung Diseases, Obstructive+”)
OR (MM “Pulmonary Disease, Chronic
Obstructive+”) OR (MM “Asthma+”)
Expanders - Apply related words
Search modes - Boolean/Phrase
18552
S9 (MM “Cardiovascular Diseases+”) Expanders - Apply related words
Search modes - Boolean/Phrase
148585
S8 (MM “Hypertension+”) OR (MM
“Cerebrovascular Disorders+”)
Expanders - Apply related words
Search modes - Boolean/Phrase
43901
S7 (MH “Diabetes Mellitus+”) Expanders - Apply related words
Search modes - Boolean/Phrase
50346
S6 S4 or S5 Expanders - Apply related words
Search modes - Boolean/Phrase
33990
S5 TI ( chronic* W3 disease? or chronic*
W3 ill* or chronic* W3 care or chronic*
W3 condition? or chronic* W3 disor-
der* or chronic* W3 health* or chronic*
W3 medication* or chronic* W3 syn-
drom* or chronic* W3 symptom* ) or
AB ( chronic* W3 disease? or chronic*
Expanders - Apply related words
Search modes - Boolean/Phrase
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(Continued)
W3 ill* or chronic* W3 care or chronic*
W3 condition? or chronic*W3disorder*
or chronic* W3 health* or chronic* W3
medication* or chronic* W3 syndrom*
or chronic* W3 symptom* )
S4 (MH “Chronic Disease”) Expanders - Apply related words
Search modes - Boolean/Phrase
21759
S3 S1 or S2 Expanders - Apply related words
Search modes - Boolean/Phrase
25441
S2 TI ( multimorbid* or multi-morbid* or
comorbid* or co-morbid* or multidis-
ease? or multi-disease? ) or AB ( mul-
timorbid* or multi-morbid* or comor-
bid* or co-morbid* or multidisease? or
multi-disease? ) or TI (multiple N2 ill*
or multiple N2 disease? or multiple N2
condition? or multiple N2 syndrom* or
multiple N2 disorder?) or AB (multiple
N2 ill* or multiple N2 disease? or mul-
tiple N2 condition? or multiple N2 syn-
drom* or multiple N2 disorder?) or TI (
coocur* N3 disease? or coocur* N3 ill*
or coocur* N3 care or coocur* N3 condi-
tion? or coocur* N3 disorder* or coocur*
N3 health* or coocur* N3 medication*
or coocur* N3 symptom* or coocur* N3
syndrom* or coexist* N3 disease? Or co-
exist* N3 ill* or coexist* N3 condition?
or coexist* N3 disorder* or coexist* N3
symptom* or coexist* N3 syndrom* or
multipl* N3 disease? Ormultipl* N3 ill*
or multipl* N3 condition? or multipl*
N3 disorder* or multipl* N3 medica-
tion* or multipl* N3 symptom* or mul-
tipl* N3syndrom* or co-exist* N3 dis-
ease? Or co-exist* N3 ill* or co-exist* N3
condition? or co-exist* N3 disorder* or
co-exist* N3 health* co-exist* N3 symp-
tom* or co-exist* N3 syndrom* or co-
ocur* N3 disease? Or co-ocur* N3 ill*
or co-ocur* N3 condition? or co-ocur*
N3 disorder* or co-ocur* N3 health* or
co-ocur* N3 symptom* or co-ocur* N3
syndrom* ) or AB ( coocur* N3 dis-
ease? or coocur* N3 ill* or coocur* N3
care or coocur*N3condition? or coocur*
Expanders - Apply related words
Search modes - Boolean/Phrase
14294
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N3 disorder* or coocur* N3 health* or
coocur* N3 medication* or coocur* N3
symptom* or coocur* N3 syndrom* or
coexist* N3 disease? Or coexist* N3 ill*
or coexist* N3 condition? or coexist* N3
disorder* or coexist* N3 symptom* or
coexist* N3 syndrom* or multipl* N3
disease? Or multipl* N3 ill* or multipl*
N3 condition? or multipl* N3 disorder*
or multipl* N3 medication* or multipl*
N3 symptom* or multipl* N3syndrom*
or co-exist* N3 disease? Or co-exist* N3
ill* or co-exist* N3 condition? or co-ex-
ist* N3 disorder* or co-exist* N3 health*
co-exist* N3 symptom* or co-exist* N3
syndrom* or co-ocur*N3disease?Or co-
ocur* N3 ill* or co-ocur* N3 condition?
or co-ocur* N3 disorder* or co-ocur* N3
health* or co-ocur* N3 symptom* or co-
ocur* N3 syndrom* )
S1 (MH “Comorbidity”)
WH A T ’ S N E W
Last assessed as up-to-date: 7 November 2011.
Date Event Description
1 May 2013 Amended Minor edits, fixed ref for Katon 2010
H I S T O R Y
Protocol first published: Issue 2, 2007
Review first published: Issue 4, 2012
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Date Event Description
24 May 2011 Amended Search updated Feb 2011
12 June 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Susan Smith (SS) conceived, co-ordinated, and designed the review.
Hassan Soubhi (HS) helped co-ordinate the review, assessed studies for inclusion, and extracted data from included studies.
Martin Fortin (MF), Catherine Hudon (CH), and TomO’Dowd (TOD) along with SS and HS contributed to all stages of the protocol
and review, and were involved in writing all review drafts and responding to peer review comments.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Health Research Board Primary Care Research Centre, Ireland.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
During the review process, the authors decided, following a suggestion from a peer reviewer, that interventions should be excluded if
they only targeted one condition as this was contrary to the emphasis on multimorbidity. This led to the exclusion of some studies
examining co-morbid depression and other conditions where the intervention was only targeted at depression treatment.
Changes were also made to the original search strategy in the protocol, based on initial results from the original searches. The searches
used in the review are presented as appendices.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Primary Health Care; Age Factors; Chronic Disease [∗therapy]; Community Health Services; Comorbidity; Disease Management;
Patient-Centered Care [methods]; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome
MeSH check words
Humans
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